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On cross section, nwst sizable tunwrs reveal three regions that differ in their blood supply 
and therefore their oxygen content. At the tunwr's core, the tissue is essentially dead be­
cause ofa Inck ofoxygen, which is shown above as the /igh/-colored dots. The dark dots 
represent accumulations ofa radiosensitizing drug that accumulates even in low-oxygen 
regions oftumors, making the cells more vulnerable to killing by radiation therapy. See 
"The Cells We're After," page 22. 
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• delivered a keynote 
speech at ceremonies designat­
ing Washington University in 
SI. Louis as an Alzheimer's 
Disease Research Center 
(ADRC). Washington Univer­
sity is one of ten institutions 
that have received five-year 
funding from the National 
Institute on Aging (NIA) to 
study Alzheimer's Disease. 
Eagleton was instrumental 
in establishing the National 
Institute on Aging and has 
worked to obtain federal fund­
ing for health care research, 
particularly through the 
National Institutes of Health. 
The center will receive more 
than $3.7 million in NIA fund­
ing over the next five years. 
A neurological disorder with 
no known cause or cure, 
Alzheimer's Disease affects an 
estimated two million Ameri­
cans and is the most common 
cause of intellectual impair­
ment and institutionalization 
among the elderly. 
The Washington University 
ADRC will take an interdisci­
plinary approach to research 
on Alzheimer's disease and 
related disorders. Established 
investigators will conduct a 
wide range of studies, examin­
ing behavioral as well as bio­
medical aspects of the disease. 
Researchers will compare the 
healthy aging process with 
that of Alzheimer's-induced 
dementia; search for neurobio­
logical factors that could be 
associated with the disease; 
explore changes in the aging 
brain that may contribute 
to Alzheimer's disease; and 
investigate the disease's im­
pact on the family and the 
community. 
The ADRC also will train 
scientists and health care 
professionals, and provide the 
public with information on 
research advances. 
The center's director, 
Leonard Berg, M.D., is profes­
sor of clinical neurology at the 
School of Medicine. He is pro­
gram director of the medical 
school's Memory and Aging 
Project, a long-term study of 
intellectual function in people 
aged 65 and older, and a physi­
cian at Barnes, Children's and 
Jewish hospitals. 
For further information 
about the new center, call 
ADRC coordinator Sandy 





vice president of 
The Salk Institute 
for Biological Studies in La 
Jolla, Calif., has been ap­
pointed provost and executive 
vice chancellor effective Au­
gust 1986, Chancellor William 
H. Danforth has announced . 
Cowan returns to Washing­
ton University where he pre­
viously served as head of the 
Department of Anatomy and 
W. Maxwell Cowan 
Neurobiology from 1968 to 
1980 and director of the uni­
versity's Division of Biology 
and Biomedical Sciences from 
1975 to 1980. 
A co-founder of the Division 
of Biology and Biomedical Sci­
ences, Cowan led a pioneering 
effort to bridge the gap be­
tween the faculties of arts and 
sciences and of medicine, espe­
cially in the graduate training 
of young biological scientists. 
The division involves several 
of the university'S scientific de­
partments - biology, anatomy 
and neurobiology, biological 
chemistry, celJ biology and 
physiology, genetics, micro­
biology and immunology, 
pathology, and pharmacology. 
The program enables young 
scientists in training to move 
freely among the disciplines in 
areas as varied as population 
biology, ecology, plant biology, 
molecular and cellular biology, 
and neural sciences. 
Cowan's association with 
the university began in 1965 
when, on sabbatical from 
Oxford University, he was a 
visiting associate professor 
of anatomy in the School 
of Medicine. 
After spending two years 
at the University of Wisconsin , 
he returned in 1968 as profes­
sor and head of the Depart­
ment of Anatomy. He also held 
a joint position in biomedical 
engineering in the Department 
of Electrical Engineering and, 
in 1978, was appointed Edison 
Professor of Neurobiology. 
In 1978, Cowan was asked 
to serve as a non-resident fel ­
low of The Salk Institute for 
Biological Studies and, in 1980, 
moved to La Jolla as a research 
professor at the Institute and 
as a senior investigator of the 
Clayton Foundation for Re­
search. In 1982, he was named 
vice president of the Institute 
and director of the Weingart 
Laboratory for Developmental 
Neurobiology. He also has 
served as an adjunct professor 
in the departments of biology 
and neurosciences at the 
University of California-
San Diego. 
A native of Johannesburg, 
South Africa, Cowan received 
his undergraduate degree from 
Witwatersrand University, 
Johannesburg, and his graduate 
degrees from Oxford Univer­
sity, England, on whose faculty 
he served from 1953 to 1966. 
Cowan, who also is the 
author of many scientific pub­
lications, currently serves as 
editor-in-chief of the lournal 
ofNeuroscience and editor of 
the Annunl. Reviews ofNeuro­
science. For II years, he was 
managing editor of the lournal 
,.
ofComparative Neurology. He 
also serves in an editorial ca­
pacity with two other scientific 
publ ications. 
He has served on the Board 
of Scientific Counselors at the 
National Eye Institute, chaired 
the Scientific Advisory Com­
mittee of the Neurosciences 




the Advisory Council of the Recipients of the most re- sory discrimination behavior. and thus at a higher risk of 
National Institute for Neuro- cent 1avits Awards include These experiments may facili- cardiovascular disease. 
logical and Communicative Harold Burton, Ph.D., profes- tate understanding of how the This is the first study of its 
Diseases and Stroke and on sor of neurobiology and asso- cerebral cortex operates in kind to examine the effect of 
the Medical Advi sory Board ciate professor of physiology learning to recognize touched diet on cholesterol levels in per-
of the Howard Hughes Medical and biophysics; and David I. objects, such as braille symbols sons with that trai t. Research-
Institute. Gottlieb, Ph.D., associate pro- and tactile gra ph ics for the ers will screen volunteers aged 
His honors include fellow- fessor of neurobiology and visually impaired. 21-60 to select those who have 
, '''­ ship in the Royal Society, and biochemistry. Gottlieb's resea rch goal is the trait, as well as a group of 
he is foreign associate of the Washington University rac- to understand the mechanisms controls who do not have the 
U.S. National Academy of Sci- ulty members have received that control the expression of defective protein. 
ences (1981) and member of eight of the 125 1avits Neuro- important neuronal properties Two other studies will test 
the American Academy of Arts science Investigator Awards during the development of the new cholesterol-lowering 
... 
... 
and Sciences, Alpha Omega presented since October 1983, mammalian central nervous drugs, one in liquid form and 
Alpha, and Institute of Medi- when the highly competitive system. He plans to use mono- the other in capsule form. ~-
cine. In 1984, he was awarded awards program began. Award clonal antibodies that recognize Researchers will use volun­
the Karl Spencer Lashley Prize recipients are selected three subsets of neurons to determine teers aged 21-70 to test for 
for Neurobiology by the Amer- times a year. when cell-specific antigens- optimum dosage and long-term 
... . 
ican Philosophical Society. The U.S. Congress gives the substances that cause anti- clearance. 
He is an associate of the awards in honor of Sen. 1acob bodies to form - are first de- More information about any 
Neurosciences Research Pro- K. Javits of New York , on rec- veloped. He also hopes to find of the cholesterol studies is 
gram and a member of the ommendation of the National out if the formation of appro- available rrom 1-4 p. m. week-
International Brain Research Advisory Neurological and priate neural connections is days at the Lipid Research 
Organization , the Society for Communicative Disorders and necessary to the development Center, 314-362-3500. 
Neuroscience (president 1977- Stroke Council of the National of cell-specific antigens. ':I The Memory and Aging 
78), the American Association Institutes of Health. 1avits suf- Project (MAP), begun at the 
for the Advancement of Sci- fers from amyotrophic lateral School of Medicine in 1979 to 
ence, Sigma Xi, the Anatomi- sclerosis (ALS) more com- conduct long-term research on 
'tJl 1I1lf(.(~ I'S
cal Society of Great Britain monly known as Lou Gehrig's intellectual function in persons 
and Ireland, the Royal Micro- disease. ALS is a degenerative ~e~dt,,( I lew aged 65 and older, seeks volun­
scopical Society, the American neuromuscular disorder, affect- teers to participate in studies 
Association of Anatomists, and ing the nerve cells that control ThIO('(~ St Udit's comparing healthy aging with 
past president of the St. Louis muscles. Alzheimer's disease. 
Society of Neurological The awards, given to inves- The project needs volunteers 
Sciences. tigators who have submitted aged 65-85 who are experienc­• 
regular research grant applica- s everal resea rch projects ing some form of memory loss 
tions for competitive review, ... at the School of Medicine anciJor dementia without obvi­
encourage research and train- need volunteers to make ous cause. They should not l\\() ing in communicative and them a success. have other serious di sease, in-
neurological pisorders. The The Lipid Research cluding stroke, heart failure, B(~s('a 1"('1 WI'S 
prestigious grants provide a Center is conducting several lung failure or cancer. For rur­
". Bf~('t'i,(\ .hn its seven-year commitment of studies on the effect of diet and ther information, contact MAP 
-~. r,- =- support to the researchers who medication on blood choles- at 314-362-2683. 
." 
.\" H lOci receive them. terol. Among the projects is The Diabetes Control and 
• • Burton'S research is de- a diet study funded under a Complications 1rial (DCCT) 
signed to learn more about three-year, $110,000 grant needs persons with insulin-
neural codes associated with from the NIH. According to dependent diabetes to partici­
wo faculty members the sense of touch. His studies the center's director, Gustav pate in one of the largest and 
will conduct research should illuminate the role that Schonfeld, M.D., an inherited most important studies of the 
for the next seven years speci fic areas of the cerebral protein defect that affects 25 disease ever performed. The 
with almost $1.5 million in cortex play in texture percep- percent of Americans is be- DCCT is a seven-year study 
funding from 1avits Neuro- tion and the way in which Iieved to make them more that will include 1,100-1,200 
science Investigator Awards. neuronal activity relates to sen- susceptible to cholesterol participants at 21 medical cen­
ters, including Washington 
, 3 
University, across the country. 
The study, funded by the 
National Institute of Arthritis, 
Diabetes and Digestive and 
Kidney Diseases, seeks to an­
swer one of the most important 
remaining questions about dia­
betes: how effective are some 
of the newer forms of diabetes 
therapy at preventing, delaying 
or reversing the presence of 
diabetic complications? These 
complications may affect the 
eyes, kidney, nerves, heart 
and blood vessels. 
Participants in the DCCT 
must be between the ages of 13 
and 39 and have had type 1 dia­
betes for 1-15 years. They can­
not be taking more than two 
insulin injections per day, be 
using an insulin pump, or have 
any severe complications from 
diabetes. Volunteers will re­
ceive free medical care for the 
next seven years. To volunteer, 
contact Julio Santiago, M.D. , 
at 314-454-6051. 
or King Fetsch, failing 
the vision test for her 
driver's license was a 
real eye-opener. 
Fetsch's low score revea led 
something she had not even 
suspected - that her eyes were 
succumbing to complications 
of diabetes. Her poor perfor­
mance would lead her to be­
come, literally, an eyewitness 
to the unfolding legacy of 
the laser. 
Mrs. Fetsch is one of 92 
patients in a landmark study 
proving that the laser can re­
verse the leading cause of 
vision loss in diabetics, a pre­
viously untreatable condition 
known as diffuse diabetic 
macular edema. That success 
has catapulted the laser, al­
ready widely used to repair 
retinas and cut away cataracts, 
into still another ophthal­
mologic spotlight. 
The latest focus on laser 's 
ability to aid lapsing vision 
could benefit many people, 
says the study 's principal inves­
tigator, because the condition 
is much more widespread than 
its rather obscure reputation 
would indicate. 
"Macular edema is the 
major cause of visual impair­
ment in all diabetics," says 
R. Joseph Olk , M.D., who con­
ducted the research at Wash­
ington University. "It doesn't 
cause people to go blind, but it 
interferes with their ability to 
read , drive, maintain a job or 
do close work . In other words, 
the necessary tasks of Ii fe." 
Macular edema, Olk 
explains, is a vision-blurring 
buildup of fluid inside the eye. 
The condition is Jess damaging 
to eyesight, but much more 
R. Joseph Olk's recent study proves that the leading cause of 
blindness among diabetics, macuJo.r edema, can be reversed 
through laser therapy. 
prevalent than the other vision 
problem common among dia­
betics, proliferative diabetic 
retinopathy. Proliferative retin­
opathy, a condition in which 
the eye's tiny blood vessels 
hemorrhage and the retina 
sometimes detaches, can cause 
legal blindness if untreated. 
Of the nearly 6 million diag­
nosed diabetics in the United 
States (and the American Dia­
betes Association estimates 
there are 4-5 million undiag­
nosed cases), nearly I in 5 re­
port some vision impairment. 
Retinopathy, which includes 
both macular edema and pro­
liferative retinopathy, is consid­
ered one of the disease's major 
complications. It is tied to du­
ration of the disease: I in 2 
diabetics will develop retin­
opathy after ten years with the 
disease, and 9 in 10 will after 
20 years. 
Olk, an assistant professor 
of ophthalmology, presented 
the first research results prov­
ing that laser therapy can al­
most always eliminate macular 
edema at the annual meeting 
of the American Academy of 
Ophthalmology in October. 
Previous studies have sug­
gested some benefits from laser 
treatments, but none have 
shown such clear results. 
A subsequent report from 
the Early Treatment of Dia­
betic Retinopathy Study, pub­
lished in the December 1985 
Archives of Ophthalmology, 
confirmed the results found in 
Olk's study. That study also 
demonstrated a positive treat­
ment benefit from argon laser 
in people who have "clinically 
significant" macular edema, 
though it used a different treat­
ment technique than Olk's. 
His new technique, called 
"modified grid," reduces fluid 
in the macula, a tiny part of 
the retina that is most responsi­
ble for sharpness of vision 
(acuity). Further, Olk reported 
that laser therapy preserves ­
and in many cases improves 
- vision already impaired by 
the condition. 
Research results published 
in 1976 proved that another 
laser technique, panretinal 
photocoagulation, can reduce 
by more than 50 percent the 
vision loss caused by prolifera­
tive retinopathy. Since then, 
laser has become routine treat­
ment for those patients. 
As Olk points out, though, 
those findings did not even ad­
dress macular edema, leaving 
a much larger group of patients 
in an ocular lurch. 
"Most ophthalmologists 
have told their diabetic patients 
that nothing can be done about 
macular edema," Olk says. 
"They have not considered any 
form of laser therapy because 
research results have not been 
very promising. Until now, 
there was no statistical evidence 
4 
that treatment is better than no "I recommend it ," she says. organ transplants and in the Society for his research on 
treatment. So the majority has "r know a diabetic with the body 's response to many dis- BCG therapy for superficial 
not been treated. Their vision same condition r have. His ease states, especially infection bladder cancer. The fellowship 
either has stayed the same, or doctor said nothing could be and cancer. and grant permit him to inves­
slowly deteriorated. done. I referred him to Dr. The Times Mirror Founda- tigate the immune response in­
"Now, ophthalmologists can Olk, and he's had two laser tion is the corporate foundation duced by mycobacterial anti-
use our results to recommend, treatments since July. Your of Los Angeles-based Times gens (the active components of 
without question, that their pa- vision is definitely worth a Mirror, parent company of BCG vaccine) in the laboratory 
~ tients with diabetic macular second opinion. " C.v Mosby as well as television of Graham Rook, a noted re­
~ 
• 
edema should undergo this station KTVI, Channel 2, and searcher in the field. 

treatment to reduce severe The Sporting News Publishing 

vision loss." Company, all in the St. Louis George E. Murphy, M.D.,
• Gil'f 	Endn\\'sOLk's findings are based on area. Times Mirror publishes professor of psychiatry and 
a three-year clinical trial of the Los Angeles Times and director of the psychiatry ~'h"di(·al
modified grid photocoagula- seven additional newspapers, outpatient clinic, has been 
tion. The study was conducted H('searc·h lAth and has other extensive media awarded a $316,000 grant 
at the School of Medicine and holdings. by the NIMH. The grant will 
Barnes Hospital. The C.v Mosby Company support an investigation of cog-
For King Fetsch, the mod- publishes medical and health nitive therapy as a specific 
ified grid laser has meant a lib- T he C.v Mosby Com- care books for students and treatment for depression. In a 
eration of sorts. The 56-year- pany and the Times professionals, and produces previous study, Murphy dem­
old widow, who received three Mirror Foundation have such electronic publications as onstrated that cognitive therapy 
treatments in her left eye as announced a $100,000 gift to educational software and test! is at least as effective as medi­
part of OLk 's study, has seen endow a pathology laboratory review materials. II cation in the treatment of 
such an improvement in vision at the School of Medicine. The depressed outpatients. The 
that her glasses need less gift is presented as part of the present study seeks to find any 
correction for that eye. ALLIANCE FOR WASHTNG- specific aspect of cognitiveFl HTIIEHMOHE 
"When I first saw Dr. Olk, TON UNIVERSITY, a $300 therapy that would explain its 
he told me that there was no million program to provide usefulness in treating this 
chance of improving my vision support for the institution. The 1986 Medical Center disorder. 
and only a 40 percent chance The funding will endow a Alumni Reunion will be held 
• of saving my existing vision," pathology laboratory in the May 1-3. Classes specially hon- Thomas E Deuel, M.D., 
she recalls. "He not only saved Clinical Sciences Research ored at the reunion this year professor of biological chern is-
it, but he improved it, too. " Building and will support the include those who graduated try and medicine and director 
She has not experienced the research of department head in 1931 and every five years of the Fixman Cancer Center 
side effects reported by most Emil R. Unanue, M.D. Unanue thereafter, including 1976. For at Jewish Hospital, has been 
other patients. is Edward Mallinckrodt Profes- more information, contact the awarded the 1985 Dameshek 
The eye that was treated is sor of Pathology at the School Alumni Office at 314-362-8278. Prize at the annual meeting 
now the one she depends on. of Medicine and pathologist-in- of the American Society 
Vision in her right eye, a con- chief at Barnes, Children's and Timothy L. Ratliff, Ph.D., of Hematology.
.­
trol during the two-year study, Jewish hospitals. research associate professor 
has deteriorated. She has just An immunopathologist, and director of urologic re- The 1985 Awards Lun­
had a third laser treatment in Unanue has investigated inter- search, division of urologic cheon, presided over by Dean ~ ,,­
.. 
-' 	 that eye and wi II learn in the actions among immune system surgery, has been awarded a Herweg, was held December 
corning months if she'll need cells. He has been instrumental World Health Organization II. At this annual event, first-
further therapy. in showing the critical role Travel-Study Fellowship and a through third-year students are 
While Mrs. Fetsch waits, played by macrophages, cells Burroughs-Wellcome Travel honored for their academic 
she's optimistic and does what which activate the body's Research Grant to conduct re- prowess during 1984-85. The 
any good eyewitness would do: immune response to foreign search at the Middlesex Hospi- prizes, and recipients, are: The 
she gives enthusiastic tes- invaders. Macrophage inter- tal in London, May-June 1986. George F Gill Prize in Anatomy, 
timony to the effectiveness ac tions with other immune sys- Ratliff is currently funded and The Kehar S. Chouke 
of modified grid laser. tem cells are important in by the National Cancer Insti- Prize in Anotom)\ awarded to 














Kenneth M. Carnes, Robert G. widely used technique to vis- at Washington University when ment. Sweet hopes his research 
Kaniecki , and Robinna G. ualize microscopic images. He Arthur Kornberg was here. eventually will lead to im-
Lorenz. is Shattuck Professor of Khorana was awarded the proved management of fetal 
The Edmund V Cowdrv Prize Pathological Anatomy and Nobel Prize in 1968 for his development during pregnancy 
in Hislology. awarded to Robert chairman of the Program in work on the genetic code. His and to a better understanding 
J Optican. Cell and Developmental Biol- presentation for the Cori Lec- of how hormones are produced 
The Dr James L. O'Leary ogy at the Harvard School ture described bacteriorhodop- in the body. 
Neuroscience Prize, awarded to of Medicine. sin, a bacterial protein that is In previous animal studies, 
RusselJ E. Hillsley. The Department of Anatomy a light-driven proton pump. Sweet and another investigator 
The Carl F (Ind Gerry T Cori and Neurobiology sponsors the isolated and described an en-
Prizes in Biochemistry. awarded Terry Lectureship, which was J. Michael Bishop, M.D., zyme that they believe forms 
to Richard C. Bell and established by alumni and was the thirteenth Carl Vernon part of a unique hormonal 
Paula J Chor. friends to honor Terry, who Moore lecturer. Bishop, profes- communication system be-
The Antoinelle Frances was department head from sor of microbiology and im- tween the fetus and mother. I 	 Dames Prize ill Physiology and 1900-41. munology, is director of The They think similar communi-
Biophysics, awarded to Hooper Research Foundation cation systems function 
Robert 1. Optican and Yasutomi Nishizuka was at the University of Cali fomi a, throughout human pregnancies. I 	 Kenneth M. Zabel. the featured speaker at the 28th San Francisco. His topic was Sweet's research is in con­
'I 
. I The Howard A. McCardock Shaffer Lecture, part of a mini- "Oncogenes: Trouble in our junction with three separately 
Book Prize in Palholof?,)\ symposium sponsored by the DNA." Oncogenes are acti- funded laboratories, includingI 
awarded to Jesse S. Little, Jr. Department of Biological vated when cells form tumors one headed by James C. War-
The DI: Margaret C Smith Chemistry and The Howard ren, M.D. , Ph.D. , professor and 
r Award, given to Laura A. Hughes Medical Institute. U.S. Sen. Thomas F. head of obstetrics and gynecol-
Rokusek. Nishizuka, of Kobe University Eagleton, D-Mo., delivered ogy. The other laboratories are 
'/ The Mediccrl Cenler Alumni in Japan, is an expert on phos- the third annual Edward Mas- in Australia and Massachu-
Scholarship Fund Prize, pholipids (fats), some of which sie Lecture in Cardiovascular setts. The investigators are col-
awarded to James A. Schiro. are involved in the activation of Disease. His talk, titled laborating on two other proj-
The Accrdemic Achievement protein kinase C. The latter "Health Care's Third Revolu- ects that examine the role of 
Award, given to Albert B. transforms normal cells into tion - Sowing Seeds for the enzyme systems important in 
Ross. tumorous ones and may be an Fourth?", honored Edward the production and regulation 
Olil 'er H. Lown' Prize ill important regulatory aspect Massie, M.D. '35, professor of hormones. 
Pharrnacology, awarded to of the process. emeritus of clinical medicine. 
Peter L Smith. Philip W Majerus, M.D. '61. Eagleton, a U.S. senator The WU School of Medi-
The McGraw-HilI Book professor of biological chemis- since 1969, has been very in- cine chapter of the Alpha 
Prizes, awarded to Kenneth M. try and medicine , was another volved in funding health care Omega Alpha medical frater-
Zabel and Russell E. Hillsley. of the symposium speakers. He research, particularly through nity initiated fourteen newly 
The Richard S. Brookings described his work on specific the National Institutes of elected senior medical students 
Medical School Prizes, awarded phospholipids that encode in- Health. He was instrumental at its annual banquet. 
to Brian A. Armstrong, Jesse formation in their structure. in establishing the National The new members are 
S. Little, Jr., and Eric E. These compounds are "second Institute on Aging, and in the Trevor C. Axford, Nancy L. 
Stevens. messengers" and are part of a mid-1970s played a key role in Bartlett, Charalabos Harris 
The Dr Robert Carter Medi- system analogous to adenylate passage of the Health Man- Chrysikopoulos, Bradley A. 
cal School Prizes, awarded to cyclase / cyclic AMP The power Act. Evanoff, Fredric 1. Gross, 
Jeffrey L Elliott, Robert M. I ipids Majerus investigates Rachel F Haft, Daniel H. 
Forstot. and HalTi ~ S. show a particular structural Frederick Sweet, Ph.D., Hechtman, 8avid A. Johnson, 
Chrysikopoulos. shape in cells stimulated to professor of reproductive biol- Jean P MoJJeston, Michael E. 
form tumors. 	 ogy, has received more than Presti , James A. Schiro, Eric 
Morris J. Karnovsky, $900,000 to continue studying E. Stevens, 0. Clark West , and 
M,n., Ch.B., D.Sc., deliv- H. Gobind Khorana pre- the role of enzymes in produc- Judith L Zier. 
ered the 32nd annual Robert 1. sented the first Carl and Gerty ing steroid hormones. The 
Terry Lecture. Karnovsky is a Cori Lecture. Khorana, now in four-year grant renews a pre-
cell biologist and experimental the departments of biology and vious award to Sweet from the 
pathologist who developed a chemistry at Massachusetts National Institute of Child 
Institute of Technology, worked Health and Human Develop-
I 
L , 6 
EADING 
QUEST 
BY LINDA SAGE 
.. 
T he Diagnostic Interview Schedule (DIS), a tool for diagnosing specific mental disorders, was born at Wash­
ington University. Now fully matured , it's 
traveling the world. From Iceland to main­
.. 	 land China, from Portugal to Puerto Rico, 
researchers are using the DIS and its 22 
translations in clinical and epidemiologica l 
studies. 
Only a few years have elapsed between 
the DIS's conception and this spate of 
globe-trotting. The need for such a tool be­
came evident in 1978 when the President 's 
Comrnission on Mental Health , asking how 
the mentally ill are served, concluded that 
information about the prevalence of mental 
di sorders ought to be linked to data on the 
use of mental health facilities. But at that 
time, there was no comprehensive infonna­
tion on either topic. 
Epidemiologic studies of mental illness 
in the US. began in 1855, when physician 
Edward Jarvis tried to determine the fre­
quency of the two major diagnoses of that 
era, insanity and idiocy. Later, other disor­
ders - such as depression and anxiety­
were defined and surveyed. But after World 
War II , most American epidemiologi sts 
either rejected the tenet of multiple di sor­
ders or decided that psychiatri sts were unre­
liable diagnos ticians. So subsequent studies 
measured blanket mental iJlness instead of 
different di sorders. Result : Some question­
T ­ able conclusions about the mental hea lth 
of Americans. For example, the Midtown
-r­
ot Manhattan Study, publi shed in 1962, co n­
cluded that 82 percent of its sample had 
psychiatric problems. 
During the 1960s and 70s, opi nion swung 
once aga in to favor specific diagnoses such 
as sch izophrenia, mania and depression . 
And during that time, psychiatrists devel­
oped tools to define the different di sorders, 
eliminating the greatest source of error in 
diagnosis: variation in diagnostic criteria 
from one psychiatrist to another. 
One such tool , the Research Diagnostic 
Criteria (RDC), grew out of ten yca rs' re­
search on di agnosis, much of it under the 
direc ti on of Eli Robins, M.D. , then head of 
psychiatry at Washi ngton University and 
now Renard Professor of Psychiatry Today, 
the Diagnostic and Statistical Manual of 
Mental Disorders (DSM-III), which evolved 
from the RDC, is the official diagnostic 
system in the U.S. and is widely used 
elsewhere. 
The DSM-IJI was in preparation when 
the President's Commission announced its 
findings in 1978. So when NIMH took up 
the Commission's cha llenge and decided to 
conduct a nationwide survey of mental 
health , it wanted to use DSM-I/J criteria. 
I t also had to fi nd a survey method. 
Early surveys assessed mental disorder 
by inspecting officia l records and ask ing 
leaders about severely disturbed people in 
their communities. So they missed all but 
the obvious cases. Later, psychiatrists began 
to do personal interviews but refrained 
from asking "embarrassing" questi ons 
about sexual behavior, violence and drink­
ing. More recenrly, they discovered that 
people are willing to admit to "deviant" be­
havior, and their interviews have become 
more comprehensive. 
Assessing the written interviews ava il­
able in 1978, NIMH concluded that one de­
veloped by Lee N. Robins, Ph.D , professor 
of soc iology In psychiatry, and her col­
leagues at Washington University, was 
closest to it s requirement. "Jt formed the 
best base from which to begin:' says Darrel 
A. Regier, M.D, M.PH .. then head of the 
Division of I3iometry and Epidemiology al 
NIM H, now director of NIMH's Clinical 
Research Division . "We needed an inter­
view that cou ld be administered to a very 
large population in order to assess di sorders 
that are found at very low prevalence. In 
order to conduct such a large-scale survey, 
we knew that we would have to use Illy in­
terviewers, which meant that the interview 
had to be highly structured. It had to repli­
cale as much as possible the clinical diag­
nostic proce~s." 
IMH sc ienti sts sponsored and coordi­
nated the development of a new diagnostic 
A psychiatric diaglwstic illterview written by Lee N Robins, lejf, al/racted sponsorship 
from NIMH because it ejfectively ullmasked low-prevalmlce disorders ill )'ery large pOpll­
liJlioll studies. Elizabeth M. Smith is examining the melltal health ofpersollS v.posed to 
jloods, dioxill alld radioactive well wata 
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interview. Working with John E. Helzer, 
M.D., professor of psychiatry, and Jack L. 
Croughan, M.D., clinical associate profes­
sor of psychiatry, and scientists Robert 
Spitzer and Janet Williams from the New 
York Psychiatry Institute, Lee Robins con­
verted the interview into the DIS by incor­
porating DSM-III criteria, adding questions 
about the recency of symptoms and making 
it scorable by computer. Then in 1981, the 
DIS took to the field in the five areas of 
NIMH's survey, which was caJled the 
Epidemiological Catchment Area (ECA) 
study. 
DIS JN THE FJELD 
The study assessed the prevalence (life­
time occurrence) of specific mental disor­
ders in and around five American cities. 
Between the two study phases, a telephone 
survey asked about the use of mental health 
facilities. The same people were inter­
viewed on all three occasions. 
The ECA study is the largest psychiatric 
epidemiologic study to date, each site being 
nearly as big as the combined total of all 
previous North American studies. With 
3,000 household residents and 500 institu­
tionalized residents at each site, the study 
surveyed nearly 20,000 people age 18 and 
older. Regions of inner cities were also in­
cluded because of their known high rates 
of psychopathology. 
The interviewers - mostly market re­
searchers and census data collectors ­
trained for eight days, where they learned 
how to ask the DIS questions and code the 
answers. They needed no prior knowledge 
of psychiatry because the questions are read 
exactly as written and because the computer 
makes the final diagnoses. The only tricky 
part was learning to use the probe flow 
chart, the interview's "road map." The 
chart directs the interviewer to a subsequent 
question on the basis of the previous ques­
tion's answer. 
After training, the interviewers took their 
expertise into homes and institutions, where 
they conducted the interviews. The results 
were then collected, cleaned and analyzed, 
giving the first assessment of the prevalence 
of 15 mental disorders. Incidence figures 
are not yet available. 
Felton J Earls is using the DiagIWstic Interview Schedule, DIS, devewped at Washington 
University in his assessments ojmental illness among adolescent populations. He says the 
DIS overshadows all the other existing interviews. 
MENTAL HEALTH IN AMERICA 
The study found that about one-third 
of the sample had experienced at least one 
psychiatric disorder sometime during their 
lives. The most prevalent diagnoses were 
alcohol abuse, phobias, major depression, 
antisocial personality (chronic amoral and 
impulsive behavior), and drug abuse. 
There was no difference at any site 
between the total prevalence of disorders 
in men and women. This contrasts with 
earlier surveys, which consistently found 
that women have more psychiatric illness. 
" It appears that the reason for this repeated 
earlier finding," conclude the research­
ers, "was that symptoms of the male­
predominant diagnoses such as alcoholism, 
drug dependence and antisocial personality 
were little inquired about." 
Researchers also uncovered a surprising 
relationship between age and incidence of 
mental disorders. They expected to find 
higher rates in older persons, who have been 
at risk for longer periods. But alcohol abuse, 
major depress ion , mania and panic disorder 
were least prevalent among those over age 
65. Drug abuse was highest among 18- to 
24-year-olds. The drug abuse results are 
understandable, the researchers say, because 
the drug epidemic began in the late 1960s. 
But the other findings have no ready 
explanation. 
Unlike the age-related findings, the effect 
of urbanization on mental health was pre­
dictable. Inner cities had higher rates of 
drug abuse, antisocial behavior, schizo­
phrenia and cognitive impairment. Only 
panic di sorder was higher in the rural and 
small-town areas. 
The study also showed that fewer than 
one-fifth of persons with recent symptoms 
had visited either a general physician or 
mental health specialist to discuss psychiat­
ric problems in the previous six months. 
And though about one in two schizophren­
ics and one in three people with affective 
disorders (mania, depression) had sought 
help, the ratio was only one in ten for 
persons with alcohol-related problems. 
"It was suspected before our study that 
there was a lack of treatment for substance 
abuse, but no one could put a number on 
it," says Lee Robins. "And what was most 
interesting to me was not the numbers so 
much as the barriers to treatment. Things 
that are easy to remedy - such as cost, 
opening hours of clinics, or not knowing 
where to get help - are not very frequent. 
People with alcohol problems think that 
they should be able to stop drinking on their 
own, that it's not a proper thing to talk to a 
doctor about, or that it's a bad habit that 
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t they will overcome. So they don't think it's 
a reason to seek care. I think that's a very 
important finding . It means that the prob­
lem is not just to improve facilities but also 
to educate the publ ic. " 
NEW STUDIES SPAWNED 
Since the completion of the ECA study, 
• 	Washington University has continued to 
work with the DIS. Helzer and Robins are 
among collaborators developing a computer­
based DIS that can be either self­
administered or given by an interviewer. 
.. - And a computer-based screening interview 
will help general physicians distinguish pa­
tients with psychiatric disorders from those 
with physical illness. Next year, the re­
searchers hope to computerize an interview 
called CIDI (Composite International Diag­
nostic Instrument), a combination of a 
British interview and the DIS. 
Other studies using the DIS as a diagnos­
tic tool include the Health Effects of Envi­
ronmental Hazards, in which Lee Robins 
and Elizabeth M. Smith , Ph. D., research 
assistant professor of social work in psy­
chiatry, are looking at the mental health of 
persons exposed to flood s, radioactive well 
water and dioxin , and the Health in Teens 
Study headed by Felton 1. Earls, M.D , 
Blanche E IttIeson Professor of Child 
Psychiatry. 
The Health in Teens Study (HITS) com­
I .. 
pares adolescents (ages 10-13) treated in tra­
ditional public health clinics with those 
cared for by consolidated clinics that pro­
vide a network of comprehensive services. 
'I 	 An adolescent with multiple problems could 
visit a clinic for, say, pregnancy but not re­
ceive treatment for her depression or drug 
abuse. In 1980, the Robert Wood Johnson 
Foundation supported establishment of 20 
consolidated clinics, each a network of ser­
vices providing comprehensive treatment. 
HITS evaluates the performances of seven 
of these compared with three traditional 
clinics in ten different cities. 
Fieldwork began in 1984, when HITS 
interviewed 3,000 adolescents who visited 
one of the clinics for any medical purpose. 
Using parts of the DIS plus the related 
, 
 Diagnostic Interview for Children and Ado­
lescents, it diagnosed the disorders that 
were present in the sample. Then in No-
How to Write Leading Questions 

"Writing an interview is really more 
an art than a science," says Lee Robins. 
"There's little in the literature about 
it except for rules about not leading 
the respondent with biased questions 
and not combining two ideas in a single 
question . " 
Compiling the 259 sets of a main 
question plus subquestions in the DIS 
began with a list of psychiatric symp­
toms compiled from DSM-I1I. For 
example, psychiatric researchers need to 
know about a client's possible heavy al­
cohol intake, recklessness, violence and 
job loss - symptoms of alcohol abuse. 
So they had to write understandable 
questions that would uncover any of 
these symptoms. "That's the hard part," 
says Robins. "A question has to be per­
fectly clear, short and mean exactly what 
you think it means." 
The questions also had to be non­
judgmental and inoffensive. "Do you 
have trouble getting along with people?" 
would probably provoke most persons to 
respond, "No." So a series of more tact­
ful questions was needed: "How many 
times have you been divorced? Other 
than when you separated just before a 
divorce, have you and your husband ever 
separated for a few days or longer be­
cause of not getting along? Did you 
separate more than once?" 
The Interview was tested on small 
groups of people, and any ambiguous or 
offensive questions were rewritten and 
tried out again . After about 50 such pre­
vember 1985, HITS re-interviewed the same 
adolescents and also reviewed medical re­
cords. After this wave is completed in May 
1986, it should reveal any differences in the 
effects of the two types of health care on the 
lives of adolescents. 
Earls says this study would be impossible 
without the DIS because of the tremendous 
cost of using psychiatrists for diagnosis. 
"Other questionnaires for lay interviewers 
do exist," he says, "but whereas they may 
have been partially tested for reliability, the 
DIS has been exhaustively tested for preci­
sion and accuracy. So the DIS overshadows 
all the other existing interviews." 
In May 1986, data from DIS-based 
studies in Asia , Europe and North America 
will be compared at a meeting of the Amer­
tests, the DIS was ready for the field . 
The probe-flow chart grew out of the 
psychiatry department's conventional 
way of asking questions. Like other 
physicians, psychiatrists probe patients 
to assess the significance and physical 
basis of symptoms, but they don't usually 
work from a script. The chart provides 
lay interviewers with written instructions 
for routine and efficient questioning. 
Following these, an interviewer asks 
a patient who admits to frequent head­
aches, "Did you tell a doctor about your 
headaches?" A "Yes" elicits, "When you 
told your doctor, what was the diag­
nosis?," whereas a "No" prompts, "Did 
you tell any other professional about 
your headaches?" Each subsequent 
answer likewise leads to one of two or 
more questions or tells the interviewer 
to enter a code for later diagnosis. 
The Interview was evaluated during 
the largest national survey of mental 
illness ever made in the U.S. - the 
Epidemiological Catchment Area study. 
During the ECA, lay interviewers' re­
sults were compared with diagnoses 
made by psychiatrists using several 
diagnostic methods including the DIS. 
Since there was good agreement on 
many items between the different meth­
ods, researchers feel optimistic about the 
DIS's validity for clinical and epidemi­
ologic studies. However, the real test will 
come in learning how well it predicts the 
respondent's future problems and his or 
her success in seeking care. ­
ican Psychiatric Association in Washington, 
DC. Moreover, the World Health Organiza­
tion is presently testing the CIDI prior 
to a large epidemiological study in nine 
countries. 
Thus, CIDI - an outgrowth of DIS ­
and the DIS itself must surely make states­
men envious. These psychiatric tools enable 
cross-cultural differences to be neutralized 
and diagnostic disputes settled , paving the 
way for progress in psychiatric diagnosis. 
Perhaps leaders in the arena of world poli­
tics would do well to emulate the vision and 





ANEW CELLULAR MOTOR 
BY SUZANNE HAGAN 
Zipping along microtubule "tracks, " organelles create a 

flurry oftraffic in cells. Kinesin, a unique cellular protein, 

piggybacks the organelles across the cell's vast inner 

spaces. But how to view this hidden world in 

the laboratory? Washington University researcher 

Michael Sheetz has coated tiny glass beads with kinesin. 

Using videotape and a microscope, Sheetz monitors the 

movement ofthese kinesin-coated beads, enabling 
 I' him to analyze the properties ofthis newest member of 
the family ofmotile proteins. il 
I 
iniature railroad enthusiasts know 
- but probably couldn't explain­
the fascination that this hobby 
holds. Even a casual observer can't help but 
be mesmerized by the sight of a locomotive, 
with a shri II whistle and puffs of smoke, 
chugging ceaselessly around the railroad 
track. Through tunnels and train stations, 
over hills and trestles, the locomotive 
continues its journey. 
There is a risk of being mesmerized by a 
different sort of transport system when you 
visit the laboratory of Michael P Sheetz, 
Ph.D., professor of cell biology and physi­
ology. A video screen in Sheetz's lab bears 
an enhanced microscopic view of certain 
cellular contents, hair-like fibers called 
microtubules. While the viewer watches, 
these microtubules seem to take on a life 
of their own. They become mini-railroad 
tracks, with barely visible " locomotives" 
zipping along on their surfaces - some­
times in only one direction, other times 
in the opposite direction. And some loco­
motives careen toward each other as if bent 
on a head-on collision: They don't stop 
or slow down, yet they don't col Iide. As 
if directed by some unseen engineer, the 
mini-locomotives streak past each other, 
continuing unimpeded . 
"On video tape," says Sheetz, "we see 
dramatic examples of multiple tracks on 
single microtubules, with organelles passing 
each other going opposite directions." View­
ing microtubules with an electron micro­
scope provides the explanation. These hair­
like fibers are each made up of 13 or 14 
tinier fibers called protofilaments. Each pro­
to filament is a separate track, enabling or­
ganelles - the tiny "locomotives" that zip 
along the microtubules' surface in cells ­
to avoid collision. Sheetz and co-workers 
have discovered that this movement along 
microtubules is powered by a unique cellu­
lar protein, kinesin. 
Kinesin is the most recently discovered 
protein that powers movement. Kinesin, 
along with another motile protein called 
cytoplasmic dynein, propels the smallest 
of organelles from one part of the cell 
to another. 
0'\ IIIE \IO\T 
The most well-known of the cell's motile 
proteins is myosin. Its sliding action along 
actin filaments, worked out by Hugh and 
Andrew Huxley in 1954, is the basis for 
muscle movement. For many years after 
the Huxleys' classic studies, researchers 
searched for the proteins that power the 
movement of substances inside cells. Dynein 
was the next motile protein to be uncovered. 
It propels cilia and flagella of some single­
celled organisms through a fluid medium. 
All cells need to move the smaller 
organelles within their cytoplasm , like the 
membrane-encased droplets that form at 
the cell's surface when it takes in sub­
stances. And a nerve cell needs to quickly 
move organelles and substances from the 
cell body - the neuron's "headquarters" 
-to the tip of its axon, a distance of up to 
a meter or more. But no one knew how this 
was accomplished. Many scientists thought 
that dynein, or a dynein-like protein, was 
responsible. 
In August 1985, Sheetz and his collabo­
rators at Woods Hole and Stanford pub­
lished the news of their discovery of kinesin. 
"In essence," muses Sheetz , "kinesin and 
dynein provide a pair of motors that move 
objects in two directions along micro­
tubules. A microtubule - which is larger 
than a single actin filament, with a lot more 
structural stability - can support two di­
rections of movement. " And because of the 
proto filaments on each microtubule, bi­
directional movement can be accomplished 
without collision. 
\\ ( HIIH ('1111 '" 
Microtubules form a fine mesh, a micro­
skeleton within cells. "There is one major 
microtubule-organizing center in the cell," 
explains Sheetz, "and that's the centriole or 
centrosome. From that emanates all the 
cell's microtubules. Recent studies suggest 
that this organizational structure gives the 
cell a directional polarity. It's very easy with 
a motor like kinesin, which moves sub­
stances from the centriole to the periphery, 
to set up a traffic pattern going from the 
centrosome to the cell membrane." 
Sheetz and co-workers think that a 
cytoplasmic dynein, or a protein similar to 
dynein, moves substances in the opposite 
direction - from the cell membrane 
toward the cell's center. ATP provides the 
energy that drives both of these motor 
proteins. 
The assay system Sheetz uses is simple. 
It consists of microtubules stabilized by at­
tachmentto glass. To that is added the 
motor (kinesin), a source of energy (ATP), 
and something to move. A good substitute 
for fragile organelles are small latex beads, 
and these are the barely visible locomotives 
that can be observed zipping along the mi­
crotubules. Kinesin has an affinity for both 
the beads and the microtubules, "walking" 
along the laller in a movement that Sheetz 
descri bes as " ... hand over hand. Perhaps 
the best analogy for all motile proteins is 
that they move somewhat like a centipede. 
There are probably at least ten 'heads' or 
'arms' reaching out from the protein and 
interacting with the appropriate filament. 
In the case of kinesin or dynein, that's a mi­
crotubule; in the case of myosin, it's actin." 
As these motile proteins " walk" along their 
filament, they don't let go; one arm is 
always attached. 
Sheetz has performed similar experi­
ments with myosin-coated beads: "Ialways 
joke when I go to seminars that I've thought 
about forming a company that would make 
myosin-coated shoes," he says with a laugh. 
"But not many people would want shoes 
that would require an actin 'roadway' and 
only let them move at five micrometers per 
second." 
\ I I C 'I I \, If 
Sheetz is buoyed by the fact that kinesin 
seems to be ubiquitous among species: 
"We've found kinesin everywhere we've 
looked." Recently, his group has developed 
an antibody to kinesin, enabling them 
to spot the protein no matter where its 
biological home. 
In collaboration with Ursula Good­
enough, Ph.D., professor of biology, kine­
sin's possible role in the movement of a 
single-celled organism will be explored . 
"Everywhere we've looked," says Sheetz, 
"from vertebrates to invertebrates, from 
cows' cells to sea urchins, we've found 
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Michael Sheetz slwws his video system thal demonstrates kilU!sin-powered movement to 
second-year student Emily Dohe. 
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gotten movement to occur and found that 
the polarity of kinesin movement along 
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microtubules is the same." 
And in all these systems, kinesin powers 
the movement of organelles at approxi­
mately the same rate, but that's no surprise 
to Sheetz: "All our experiments are in the 
test tube, outside of the cell, so there's no 
inhibition of movement by surrounding 
cytoplasm. When you go into cytoplasm, 
however, there's a dramatic three­
dimensional network - a latticework or 
cytoskeleton - in which there are pores of 
varying sizes. The organelles that are mov­
ing along microtubules are roughly the 
same size as these pores or gaps in the 
cytoskeleton. Consequently, they're con­
stantly bumping into it. To the extent they 
adhere, they slow down. So it's thought that 
the cytoskeleton acts as a molecuJar sieve, 
and that it's inhibiting the movement of the 
large organelles more than it's inhibiting 
the movement of smaller ones." 
For unusually shaped cells like neurons, 
in which a long projection - the axon ­
extends away from the cell body, "we be­
lieve that kinesin is the motor which drives 
objects from the cell body to the synapse," 
says Sheetz. "We believe that the motor 
driving things from the synapse back to the 
cell body is the dynein-like protein we're 
trying to isolate." 
This work will continue at Washington 
University in collaboration with Mark B. 
Wi liard, Ph. D., professor of neurobiology 
and biological chemistry. Sheetz is also 
working with Robert H. Waterston, M.D., 
Ph.D., associate professor of genetics and 
anatomy and neurobiology, on different 
types of myosin from mutant worms. They 
want to know how in vitro movements of 
myosin-coated beads correlate with the un­
usual movements that can be seen in worms 
that have these mutations in muscle myosin. 
Together with Elliott L. Elson, Ph.D., pro­
fessor of biological chemistry, Sheetz will 
study movement of intact cells on cover-
slips, to see what relative roles kinesin and 
myosin play in this type of cell movement. 
Sheetz continues collaboration with his 
long-time Woods Hole colleague. They are 
cloning the gene for kinesin to investigate 
the "nuts and bolts" of which amino acids 
are linked together to form the protein. 
"With the tools we have now," says 
Sheetz, "the video systems, the gene clon­
ing, the antibody production techniques ­
it's possible to take a phenomenon, such as 
axonal transport, and go quickly from the 
phenomenon to a protein - cloning the 
gene - in two years. 
"We know what kinesin is, but there are 
many unresolved questions," he continues. 
"How is kinesin controlled? What tells an 
organelle to move? There are some ques­
tions that are harder to crack than others. 
But now the technology is in hand to ad­
dress a number of problems that were out 




BY KAREN BURNS 
The immune system is both ally and adversary to the human body. lts warriors, so adept at fending off 
ominous foreign microorganisms, have also 
stubbornly resisted entry of the good guys 
- hea.lthy organs needed to replace those 
that are diseased and dying. 
This battle is truly one of life or death. 
But thanks to the persistence of the medical 
community, organ transplantation is enjoy­
ing its greatest success ever. Immunosup­
pressive therapy, surgical acumen and other 
advances such as monoclonal antibodies 
and cryogenics are improving the odds fa­
voring organ transplantation; now it is pos­
sible for seriously il I patients to be restored 
to near-normal. Although the cost of a 
transplant remains high, many insurance 
companies that once viewed the operations 
as experimental (and therefore refused 
coverage) are beginning to pick up the tab. 
At Washington University School of 
Medicine, success is most evident in the 
ever-growing list of organs transplanted: 
Liver, heart, cornea, pancreatic cell, and 
long-bone transplants - called allografts, 
or homografts, because they are from one 
patient to another - are joining the well­
established kidney transplant program (600 
done to date). Revival ofan old idea is 
underway in the transplantation of aortic 
and pulmonary homograft heart valves, and 
the tiny incus and stapes of the middle ear 
have joined the list, too. Preparations are 
also being made for clinical heart-lung 
transplantation, and small bowel transplants 
are being studied in the lab. 
Autotransplantation - the process of 
transplanting an organ in the same body ­
continues to be viable therapy in plastic sur­
gery, where distant components of the body 
are used to reconstruct faulty areas; skin is 
being transplanted in burn patients; and 
bone marrow autografts are helping people 
survive the treatment for certain types 
of cancer. 
But even with these advances in organ 
transplantation, we've won only half the 
battle. According to the Journal oftile Amer­
ican Medical Association (.lAMA), almost 
20,000 people will suffer brain death from 
trauma this year, yet only 15 percent will 
become organ donors. And there are at least 
100,000 potential recipients nationwide, 
more than 100 in St. Louis alone . .lAMA 
says the organ shortage is exacerbated by 
several factors: people fail to will their 
organs before they die; family members re­
fuse to donate the organs of the dead; hospi­
tal personnel neglect to ask for organ dona­
tions; available organs cannot be matched 
with recipients; and organs are allocated 
improperly. A bright spot is that multiple­
organ donors are increasing, sometimes al­
lowing as many as ten recipients to benefit 
from the organs from one donor. 
Some states are considering - and oth­
ers have passed - required request laws. 
.lAMA states that as a result of those laws, 
M. Wayne Flye is director ofthe organ 




physicians will be required to notify the 
nearest organ procurement agency when 
brain death occurs in patients who have 
willed their organs. Upon brain death in 
a person whose wishes regarding the fate of 
their organs are unknown, physicians will 
be required to request that the family 
consider organ donation. 
According to M. Wayne Flye, M.D., 
Ph.D., professor of general surgery and di­
rector of the organ transplantation program 
at Washington University, the best way to 
donate an organ is to make the decision 
"out of the stress" of the catastrophic event. 
"[t is really up to each individual," says 
Flye, "to make a decision to donate organs 
before death, and to make this wish known 
to family members so they can carry it out." 
Flye says that physicians should also 
examine their feelings about organ trans­
plantation so they are prepared when a 
donor is available. Because of increased 
public awareness of organ donation , more 
and more families initiate donation when 
death of a loved one is near. (A January 
1983 Gallup Poll showed that 93 percent of 
those polled were aware of organ transplan­
tation and of those, 72 percent said they 
would give permission to donate kidneys or 
other vital organs; 80 percent said they were 
aware of organ donor cards.) Flye adds that 
physicians themselves often donate the or­
gans of their deceased fami Iy members: 
"We're seeing more and more of that," he 
says. "And it's just as difficult a decision 
for them." 
TRANSPLANTSUCCESSSHAREO 
Flye came to Washington University last 
year to perform the center's first liver trans­
plants at Barnes Hospital, and he is pleased 
with the results. Overall, Washington Uni­
versity's transplant success rates are com­
parable to those at other major transplant 
centers: kidney transplants here have an 
80-85 percent success rate; livers, a 65-75 
percent success rate; hearts, 80-85 percent; 
and corneas and long bones, almost 
100 percent. 
As quickly as he quotes success rates and 
extols the merits of transplants for the recip­
ients, Flye just as quickly - almost in the 
same breath - remembers the donors with 
deep gratitude. "Transplantation of these 
l6 
living ti ssues is only possible because of the 
generosity of anonymous donors and their 
families," stresses Flye, attending surgeon 
at Barnes, Children's and Jewish hospitals. 
Heart transplant surgeon R. Morton 
Bolman Ill, M. D., assistant professor of 
cardiothoracic surgery who came to Wash­
ington University last year, agrees and adds: 
"It is incumbent upon us as physicians and 
healthcare personnel to be aware of the 
need for donated organs so others can be 
given a chance to live." 
Washington University is among the 
growing number of select medical centers 
that have a mUlti-organ transplant program. 
The university's transplant team, which in­
cludes six nurse coordinators, is on call 24 
hours a day. In addition, the university is 
affiliated with the Mid-America Transplant 
Association and is plugged into the national 
computer lines that record available organs. 
The transplant team also has a jet on 24­
hour standby that flies them on " lifeguard" 
status. The status gives them top-priority 
air space for optimum travel time. The jet 
and other up-to-date procurement tech­
niques make it possible for them to retrieve 
and use any organ from almost any dis­
tance. 'The transplant surgeons here have a 
personal commitment to making thi s a fine, 
active transplant program," says coor­
dinator Judy Dickens, R.N. "They spend a 
good part of their time and effort not only 
directing it, but also going out and imple­
menting it." (Heart transplants have been 
performed at both Barnes and Children's 
hospitals.) 
Much of the success of organ transplanta­
tion, here and elsewhere, has been due to 
immunosuppression by cyclosporine, either 
alone or in combination with other drugs. 
Washington University was one of the first 
to use a regimen of cyclosporine combined 
with Imuran and prednisone; heart trans­
plant surgeon Bolman says the combination 
relieves blood pressure and kidney com­
plications created when cyc\osporine is 
given alone. 
Another reason for the success is that 
doctors are more selective of their recip­
ients, who should be free of other disease 
and have good overall function of other 
organs. 
The oldest and best-established compo­
nent of the university program involves kid­
ney transplants, which are the only trans­
plants other than bone marrow that involve 
a living donor. The program began in 1963 
and has been actively promoted and directed 
by Charles B. Anderson, M.D., since 1973. 
"Kidney transplantation is now the pre­
ferred method of treating most patients with 
end-stage renal disease, especially those 
younger than 55," says Anderson, head of 
general surgery. "But even though it's a rou­
tine operation, it's still an evolving field . 
We have a lot to learn. " 
Anderson and his colleagues want to 
learn why some kidney transplants work 
and others don't. 
Kidney transplants have long been a via­
ble alternative to dialysis, partly because of 
Medicare's early decision to be responsible 
for providing treatment for permanent end­
stage renal failure. At Washington Univer­
sity, the living/re/ated transplant's success 
is primarily due to donor-specific blood 
transfusions, a method that was developed 
here in 1971. The protocol involves trans­
fusing the kidney donor's blood to the recip­
ient three times over the six weeks before 
the transplant is performed. At the same 
time, the recipient is given immunosuppres­
sive drug therapy. The process "tricks" the 
body into accepting foreign tissue and has 
resulted in an 85-90 percent success rate, 
says Anderson, general surgeon-in-chief 
at Barnes Hospital. 
Anderson's transplant group is also 
studying immunosuppression with azathio­
prine, as well as trying to identify methods 
of decreasing rejection by altering prosta­
glandin production. Another area of re­
search is the donor-recipient relationship 
between husbands and wives; those trans­
plants so far have been successful. 
A major advance in fighting renal allo­
graft rejection is in the area of monoclonal 
antibodies. Flye and hi s colleagues recently 
published the result s of a study of OKT3 ­
a murine monoclonal antibody that reacts 
with , and blocks the function of, the T3 an­
tigen on human T cells. In a study of 129 
patients, rejection was reversed in 71 per­
cent, with 61 percent of the grafts function­
ing after 12 months. The study showed that 
OKT3 is an effective treatment for acute •. 
renal allograft rejection that is uncontrol­
• • 











lable by present conventional treatments. 
"With the addition of heart and liver 
transplants, this has become one of the pre­
miere centers in the world for transplanta­
tion - both clinically and experimentally," 
says Anderson, attending surgeon at Chil­
dren's and Jewish hospitals. 
OLD IDEA HEBOB.N 
One of the newest areas of organ trans­
plantation at Washington University in­
volves aortic and pulmonary valve allo­
grafts. The operation was first done in 1962 
in England and New Zealand but didn't be­
come popular in the U.S.: Techniques for 
sterilizing, storing and preserving the valves 
resulted in shortened graft function. Xeno­
grafts and mechanical valves were the main­
stays, despite side effects like thrombo­
embolism and infection, and difficulties 
with anticoagulation and hydraulic func­
tion. All these problems cause significant 
morbidity and mortality and are especially 
troublesome in younger adults and children. 
This group has had a five-year complication­
free survival rate as low as SO percent. 
New preservation methods have changed 
all that, according to Richard A. Hopkins, 
M.D. , assistant professor of cardiothoracic 
surgery, who performs valve transpl ant op­
erations. The technique - using antibiotic 
ste rilization and DMSO-liquid nitrogen 
freezing (a technique similar to that used 
for preserving sperm) - has made human 
valves a viable alternative. Some of the ad­
vantages include nature's better engineering 
design, resulting in optimal function, and 
freedom from thromboembolism and he­
molysis. Also, larger valves can be fitted 
into smaller patients (for better perfor­
mance) and the patient doesn't need to be 
anticoagulated , as is needed with mechani­
cal valves. Since the procedure is often 
done in small, active children, not needing 
to give anticoagulants is significant, says 
Hopkins. 
Another significant difference between 
heart valves and other transplanted organs 
is that the patient doesn't need immunosup­
pressant therapy, though the reasons aren't 
yet clear why valve leaflets resist rejection, 
says Hopkins, attending surgeon at Barnes 
Hospital. Excellent valve function has per­
sisted in some patients for up to IS years. 
"This [valve transplants] will eventually 
take place in all medical centers doing state­
of-the-art surgery because the performance 
of these valves is so much better," says 
Hopkins, who trained in London at The 
Great Ormond Street Hospital for Sick 
Children, where SO such operations are per­
formed a year. "I tell my patients that the 
engineer on this valve is a lot better than 
any of our engineers - the valves are really 
better than anything we could make. " 
Donated valves come from hearts that 
are not transplantable. The procedure to do­
nate the valves is the same as any organ­
if a donor is available, a transplant center or 
agency should be called. And, like sk in, 
corneas and long bones, the valves can be 
removed for up to 12 hours after the donor 
has died, and can be stored almost indefi­
nitely. This differs from the vital organs­
kidney, liver, heart and heart-lung - that 
must be removed from the brain-dead 
patient before the heart stops. 
Heart valves, like all transplantable 
organs, are life-saving. Unfortunately, 
physicians can't save every patient from 
death. However, through transplantation, 
they can grasp back from death something 






BY SUZANNE HAGAN 
Newsweek calls them the "doctors you can't see." They're the anesthesiolo­gists and anesthetists - physicians 
and nurses - hidden behind the ether 
screen . They staff the intensive care units, 
snatch the dying from death 's grasp, and 
give the gift of relief to patients suffering 
chronic pain. They're the untouted "intern­
ists of the operating room," who help in 
the surgical miracles that happen every day. 
Giving anesthesia to any patient, says 
William D. Owens, M.D., Mallinckrodt 
Professor and head of anesthesiology, is 
very much like conducting an orchestra: "In 
anesthesiology, many potent drugs that allay 
consciousness and pain must be titrated ­
carefully administered in measured doses 
- for an individual patient. A poor titration 
is much like what you hear as a symphony 
orchestra is warming up; sounds come from 
every which way and none of it is harmo­
nious. When anesthesia is titrated properly, 
though, it 's like an orchestra playing beauti­
ful music. 
"In one sense, anesthesia's safety hasn't 
really changed much in the last 35 years," 
reflects Owens. "The mortality related to 
anesthesia in healthy young people is about 
one in 10,000. That's about the same as it 
was in the late 1940s. But on the other 
hand, we're taking sicker and sicker people 
to the operating room and doing more ex­
tensive, prolonged surgery on them. So 
even though the numbers are about the 
same, we must be improving on safety or 
those other patients would have rai sed the 
mortality and morbidity." 
Anesthesia has progressed remarkably 
since the days of ether, which posed a con­
siderable explosive hazard and made pa­
tients extremely nauseous. "We can sedate 
people without totally removing them from 
their conscious state," says Owens. "It's not 
the same as the ' twilight state,' which for­
merly was used during labor and delivery 
and took advantage of anesthetics we don't 
use today. But the end result is much 
the same." 
GOING UNDER 
The anesthesiologist must make alJow­
ances for the weakened physiological state 
of the patient about to undergo surgery. 
Another important consideration is the type 
of medication the patient may be taking. 
"Someone with rheumatoid arthritis may 
take a great deal of aspirin, which increases 
bleeding time - such patients' blood 
doesn't clot as well ," points out Owens. 
"Consequently, blood loss is higher, and 
there's a greater chance of needing a trans­
fusion in these patients. There are inter­
actions between many of the heart medica­
tions and anesthetics, and between many of 
the tranquilizers and sedatives - the sleep­
ing piJJs people take at home, even the over­
the-counter medications. It's very important 
that the anesthesiologist know what medica­
tions a patient is taking. We can work 
around them in most cases; there are only 
a few that we need to have them taken off." 
Carey I. Weiss, M.D. , instructor of anes­
thesiology and director of anesthesiology 
for organ transplants at Barnes Hospital, has 
been involved in every liver transplant that's 
been done at the medical center. Weiss, also 
acting director of cardiac anesthesiology, is 
pleased with the progress of the organ trans­
plant program. But he points out that popu­
lar perceptions of anesthesiologists' duties 
are rife with misconceptions: "As anesthe­
siologists, we need to provide the patient a 
comfortable and anxiety-free perioperative 
period and provide for the goals of anes­
thesia - amnesia and analgesia. But a lot 
of times, that's not the hardest part of 
our job. 
"We must achieve analgesia and amnesia 
in a way that causes no harm to come to the 
patient and in many cases, enhances the pa­
tient's condition, and that's very difficult," 
he continues. 'The other part of our goal, 
in addition to patient comfort, stability and 
preservation of homeostasis, is to provide 
an adequate - if not ideal - work ing envi­
ronment for the surgeon. 
"If only pentothal was as perfect as peo­
ple think it is," muses Weiss. "We simply 
don't have in our armamentarium the 
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anesthetic drug that will accomplish all 
these goals. What we need to do, for most 
patients, is pick out a balance of imperfect 
drugs. In cardiac anesthesia, many drugs 
can provide anesthesia, but they all have 
different liabilities for the heart or lungs. 
Our job is to know the patient's patho­
physiology well enough, and our phar­
macology well. enough, so we can pick the 
right drug combination without pushing 
things to the toxic level." 
Anesthesiology is really a meld of phar­
macology and physiology, says Weiss; 
neither is more important than the other. 
Cardiac anesthesia may be made up of 
perhaps a dozen drugs. "Benzodiazepines 
.'1 will be used to produce part of the anmesic 
state, as well as scopolamine," Weiss says. 
." 	 "For profound analgesia, high doses of po­
tent opioids are commonly used. That still 
doesn't help us provide the immobile field 
- muscle relaxation - required by the sur­
geon, so we'll use a muscle relaxant. All of 
those we'll try to blend because they also 
interact with the cardiovascular and pulmo­
nary systems in ways other than producing 
anesthesia. Some will raise heart rate, some 
will lower heart rate, some will depress the 
heart's ability to work, some will increase 
the heart's ability to work. All of them we 
try to blend to provide a smooth and stable 
course for the patient." 
Liver and heart transplants involve fun­
damentally different considerations, says 
Weiss. Although in both, the overwhelming 
problem is the major defective organ, pa­
tients who need a liver transplant have 
healthy hearts, with good cardiac reserve. 
Their problems are determined by the 
specific type of liver pathology affect­
ing them. 
"If the pathology is an impedence of por­
tal blood flow," says Weiss, "then we'll get 
into all the problems of portal hypertension 
and enlarged collateral venous tracts, and 
all the bleeding that will create, together 
Carey I. Weiss directs anesthesiology for 
organ transplants at Barnes Hospital. 
with the possibilities of gastrointestinal 
hemorrhages and varices - just a legion 
of problems from one perturbation. Most 
transplant patients with liver problems have 
low blood albumin and poor nutritional 
status. That changes the way you need to 
induce anesthesia. 
"An impaired liver can't produce proteins 
that clot the blood. There will be a cascade 
of interrelated problems that need to be 
handled. If we're doing a good job for the 
surgeon and the patient, all the surgeon has 
to worry about is the procedure. Our job is 
to take care of the patient in such a way that 
homeostasis is preserved. That means that 
as blood or fluid is lost, we replace it, or as 
any other changes occur, we work to keep 
the patient on an even keel." 
Several liver transplants have been per­
formed on children, the youngest only six 
months old, entailing special considerations 
for this group of patients. 'They're not just 
small adults," points out Weiss. "Their 
physiology is different." 
Weiss collaborates with pediatric anes­
thesiologists to select just the right drug, 
or assortment of drugs, to enable the surgery 
to proceed smoothly. But medical problems 
are only one facet of the problems faced by 
anesthesiologists. Patients about to undergo 
surgery may be overwhelmed by anxiety. 
"If their health dictates that they need to 
have some operation," says Owens, "we can 
tailor some kind of anesthetic for almost 
anyone, and do a good job of helping them 
pull through the operation and take care 
of them post-operatively. 
'The fear of the unknown is by far the 
biggest fear," he concludes. "Patients would 
do themselves a big favor if they would just 
open up with their anesthesiologist before 
surgery and let the questions come out, be­
cause we can answer them. No one should 
put off having anesthesia and surgery today 
because they think it's too risky." 
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orne people take the direct route 
to get where they're going in life; 
others meander around a bit Scott 
Selleck, a fifth-year student in the Medical 
Scientist Training Program (MSTP), is a 
meanderer. "[ moved around a lot when [ 
was growing up," reports Selleck, a native 
of Saskatoon, Canada. "[ lived in Brussels 
from when 1 was six years old until 1 was 
about II." Another move to Ithaca, NY, 
allowed Selleck to finish high school and 
enroll in a marine biology program, spend­
ing 1976-77 at a field station in Grenada. 
After transferring to McGill University for 
a year, he moved to the U. of Washington 
in Seattle, where he finished his studies 
in marine biology. 
After graduating with a RA. in zoology, 
he couldn't find a job in marine biology, 
partly because as a Canadian, he couldn't 
work for any U.S. national oceanographic 
concerns. To make ends meet, he hired on 
as a cashier in a bus depot for eight weeks. 
Finally, he got a job as a hospital technician 
in Seattle, spending two years researching 
drugs that produce defects in embryos, to 
see what role maternal metabolism exerted 
in either causing the defect or protecting the 
embryo. It was this job that kindled his in­
terest in returning to school and the M.ST? 
(medical scientist training program, whose 
graduates earn an M. D. and Ph. D.) at 
Washington University. 
'Td actually not thought about going 
into medicine but was interested only in 
research at that point," remembers Selleck. 
But he elected to work for a while as a vol­
unteer at the hospital, to get an idea of what 
clinical medicine was like. And that was 
another turning point in his life. He met 
many patients who were in desperate emo­
tional straits. Some had no families ; others 
were dying or suffering from chronic ill­
nesses: " You get a perspective on what professor of biological chemistry. There, "I like the questions that Sean asks me, 
you're doing in the lab by working with using yeast DNA, he looks for "footprints" things that maybe he wouldn't ask his 
patients," he reftects. "It emphasizes how that demarcate the chromosomal points mother. And it gets me out, doing the things 
research is much more than simply an where the production of m-RNA - the 1 like to do but wouldn't have made time for." 
intellectual game." "messenger" that directs protein synthesis As far as Sean is concerned , having a Big 
Today, as a student who's completed one - first begins. Brother is the perfect complement for the 
year towards his M.D. and is enmeshed in Yet his busy research career doesn't "grueling" life of an II-year-old fifth 
research towards his Ph.D., Selleck doesn't eat up all his time. He participates in the grader: "We do lots of things together," says 
stray much outside the environs of the labo­ JCCA's Big Brother program. His two years Sean, "like go to [St Louis Soccer] Steam­
ratory of John E. Majors, Ph.D., assistant as a Big Brother have been as rewarding for ers games, or to the museum, or bowling or 
him as for his Little Brother, Sean Sedach. 
Scott Selleck is "Big Brother" to Sean Sedach. Selleck was honored in September for his 
longterm participation in the Big Brother/Big Sister Program sponsored by the Jewish 
Community Centers Associntion. (plwto by David Henschel) 
--
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golfing. We' ll usually go out to eat, too." 
They see each other once a week or every 
other week , says Sean , and between milk­
shakes and movies, there's plenty of time 
for talking: "We talk about lots of things," 
says Sean, "like my problems, or anything 
going on with me."
.. 
In appreciation for Selleck's participa­
tion, the JCCA honored him last September 
as "Big Brother of the Month ." Taking ad­
vantage of opportunities like the Big 
Brother program isn't unusual for someone 
like Selleck, whose future isn't confined 
to a university research setting. 
One of the appealing things about the 
MSTP is that it increases his options for the 
future, says Selleck: "Graduates can go into 
pure science, or clinical work, or even a 
government job setting health policy. The 
education we receive trains us for an amaz­
ingly wide variety of positions in research 
and health care." 
Currently, Selleck is one of 92 students 
enrolled in MSTp, a program begun 16 
years ago thanks to a then-new National 
Institutes of Health program channeled 
through the National Institute of General 
Medical Science. In 1969-70, ten students 
enrolled in the Washington University pro­
gram initiated by Roy Vageles, M.D., 
Ph.D. , then chairman of the Department of 
Biological Chemistry and now president 
of Merck and Company, Inc. The program
' . 
concept was vigorously supported by Luis 
Glaser, Ph.D., Carl Frieden, Ph.D., and 
Barbara Fox. Today, these same three per­
,':' 	 sons (Glaser and Frieden are co-directors, 
and Fox is assistant director) still steward 
a training program that is, according to Lee 
Van Lenten, M.D., the national program 
administrator at NIH, "one of the top pro­
grams in the country. It's very successful 
- our peer review group just returned from 
a site visit there, and they were very favor­
ably impressed." 
In 1964, when the NIH first provided 
funding for medical scientist training pro­
grams, only three schools participated. 
• Today, reports Van Lenten, 25 schools 
across the nation - with 683 students ­
receive funding from the NIH for their pro­
gram, supported by grants totalling $12.6 
million. 
The NIH's MSTP grant provides about 
half the support needed for the WU pro­
gram, says Fox, with the university provid­
ing the remainder. "Without the university's 
support, we couldn't enroll the number of 
students we do," reports Frieden. Several 
schools, he says, have only NIH support and 
can accept only a small number of students. 
"Thus far," says Frieden, "we've gradu­
ated about 90 students. About half have 
completed their residencies, and almost all 
are in research settings today. Our success 
rate in training academic scientists, skilled 
in clinical and basic research , is even better 
than the NIH envisioned." 
Frieden heads the MSTP admissions 
committee, which has representatives from 
all the preclinical departments at the School 
of Medicine as well as the Department of 
Medicine. "The faculty is very committed 
to, and enthusiastic about, the MSTp," says 
Frieden. "These students represent a really 
top-notch groufl, and they're fun to have 
around . At any given time, they represent 
about a fourth of our graduate students, and 
they contribute enormously to that group. 
They enhance both graduate and medical 
education. " 
"The MSTP was the first inter­
departmental educational program we ever 
had," says Glaser. "It set the stage for the 
formation of the Division of Biomedical 
Science. The MSTP and our graduate pro­
gram benefit from each other since they 
each attract a unique flavor of student." 
The NIH is keenly aware of this advan­
tage and has boosted support for this pro­
gram through the years, says Van Lenten. 
"In 1979, the NIH spent about $7.7 million 
to support 666 students," he reports. 
"Today, we fund about the same number of 
students - 683 - but it costs much more, 
$12.6 million. The monetary increase has 
been primarily in tuition increases, although 
we have increased the amount of the 
stipend." Currently, Washington University 
provides each MSTP student with a stipend 
of $7,250. 
One of the program's strengths, says 
Frieden, is the fact that it only accepts 
students who have done some research . 
Another, pointed out by Van Lenten, is the 
strong recruiting program: "They have gone 
out even to the smaller schools and made 
themselves known," he points out. "Not 
every university does this." 
So what kinds of students does the pro­
gram attract? Very good ones, like Scott 
Selleck, with strong academic records and 
proven ability as researchers. "In many 
ways, Scott is typical of the student who 
comes through the program ," muses 
Frieden, "but he's perhaps had a more di­
verse range of experiences. Overall , this is 
a group of students who can simultaneously 
do a number of things well." 
"Our students are perhaps our greatest 
challenge," says Fox with a laugh. "Carl 
Frieden and Luis Glaser are really open to 
student input when it comes to program 
policy and procedure. Student suggestions 
are implemented whenever feasible, and 
they have greatly influenced the direction 
this program has taken. Scott is one of our 
most active students, and he really keeps us 
on our toes." 
EDITOR'S NOTE 
The hard-working and enlhusiaslic admis­
sions committee for the MSTP currently con­
sists ofthe following members in addition to 
Glaser and Frieden: Irving Boime, Ph.D., 
professor ofpharmacology and obstetrics/ 
gynecology; Thomas J Braciale, M.D., 
Ph.D., associate professor ofpathology; 
Jonathan B. Cohen, Ph.D., professor of 
neurobiology and biological chemistry; Paul 
J DeWeer, MD., Ph.D., professor ofcell biol­
ogyandphysiology; Elliot L. Elson, Ph.D., 
professor ofbiological chemistry; Ted H. 
Hansen, Ph.D. , associate professor ofgenet­
ics; David!. Gottlieb, Ph.D., associate pro­
fessor ofalUltomy and neurobiology and bio­
logical chemistry; David Schlessinger, PhD. , 
professor ofmicrobiology and immwwlogy 
and medicine; John L. Schultz (ex officio), 
assistanl dean and registrar, School ofMedi­
cine; Douglas Tollefsen, M.D. , Ph.D. '77, 
assistant professor ofbiological chemisuy 












After several years "back at the drawing board," researchers at Washington University and else­
where are now ready to begin major clinical 
trials of a drug thought capable of increas­
ing up to two-fold the effectiveness of anti­
cancer radiation thcrapy. 
The drug SR-2S08, when present in 
a tumor, helps ensure that the damage 
caused by radiation treatments will be 
irreparable and lethal to cancer cells, says 
Todd Wasserman, M.D., radiation therapist 
at Washington University and chairman of 
the group that will test the drug on cancer 
patients. 
Hopes are high for SR-2508 because lab 
tests and an initial clinical trial indicate the 
drug enhances radiation and penetrates 
tumors more uniformly than previously 
tested drugs. In addition, SR-2508 does not 
exhibit the major side effects that have 
forced physicians to hold the dose of other 
"radiosensitizers" to less-than-effective 
levels. 
Results of the Phase I clinical trial 
and plans for wide-scale Phase III test­
ing at 15 to 20 U.S. and Canadian medical 
Cross section through two lobes ofa solid 
tumor. Researchers are using "sensitizing" 
agents to make cells between the tumor's 
core and periphery more sllsceptible to 
radiation therapy. 
CLAYTON 
centers were announced during the Confer­
ence on Chemical Modifiers of Cancer 
Treatments, held recently in Clearwater, FL. 
Wasserman. involved in radiosensitizer 
research tor eight years, chaired the session 
in which the SR-2508 report was presented. 
The report reflects data from trials at Wash­
ington University, Stanford. University of 
Calit()rnia-San Francisco, and University 
of Alberta in Canada. 
"The safety of SR -2508," says 
Wasserman , "enables us to give doses 
three times higher than we could with other 
radiosens.itizers. Because of the way SR­
2508 is administered and the way the body 
handles the drug, it can be given to patients 
on a schedule compatible with the five­
times-a-week schedule preferred lor radia­
tion treatments." 
Phase III clinical trials of SR-2508 
will be conducted by the Radiation Therapy 
Oncology Group (RTOG), funded by the 
National Cancer Institute. Twenty-one med­
ical institutions arc currently full members 
of the RTOG, although each does not neces­
sarily participate in every study. 
The SR-2508 trials, scheduled to be 
underway by mid-1986, will involve a vari­
ety of tumors including advanced bladder, 
prostate, and head and neck cancers. 
Wasserman, chairman of the RTOG com­
mittee coordinating the trials. says that 
Washington University researchers will use 
the drug on selected patients with each of 
these types of cancer. 
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"These trials will include hundreds of enough to develop central nervous system several teams of chemists and biologists to 
patients, and should take from three to five 
years," Wasserman says. SR-2508 will be 
given intravenously three times weekly 
throughout a standard course of radiation 
therapy, five to six weeks. Patients who 
receive the drug and radiation will be com­
pared to similar patients who receive 
radiation but no SR-2508. As in the past, 
Washington University patients will be ad­
mitted to the General Clinical Research 
Center during the administration of their 
therapy. 
EARLY FAILURES 
The sensitizer that oncologists have the 
most experience with is mi sonidazole, or 
"miso," a precursor to SR-2508. By the late 
1970s, several institutions had begun clini­
cal trials with miso. While some of miso's 
properties made it appealillg, others soon 
led to problems. Administered in pill form, 
miso caused nausea and vomiting. It could 
cross the blood-brain bar rier and cause 
nervous system side effects. 
"In the time that I was involved in miso 
therapy here at Washington University, I 
can't remember encountering any patients 
who remained on the medication long 
toxicities," recalls Faye Jennings, a super­
visory nurse in radiation oncology. "How­
ever, other centers did report such effects." 
Wasserman, with James S. Nelson, M.D., 
a Washington U. pathologist, confirmed that 
miso could cause observable physical dam­
age to the myelin sheath around peripheral 
nerves. 
"The neuropathy reported was always 
temporary, but sometimes severe," says 
Wasserman. "There were reports of the 
same type of peripheral neuropathy we still 
have with SR-2508, but there were also re­
ports of patients who had exhibited a state 
of confusion during their course of therapy. 
On top of that , even when we thought that 
ample doses of miso penetrated the tumor, 
the cancers didn't respond as well as pre­
dicted. The severity of the side effects dis­
couraged researchers from further increas­
ing the dose of miso administered. 
"Considering all the factors pointing 
toward success, miso's failure made it in­
cumbent on us to find out what the problem 
was," recalls Wasserman. "The whole area 
of research fell into a slump while we 
retrenched. " 
The National Cancer Institute asked 
develop rni sonidazole analogs, hoping that 
some might be even more potent radiosen­
sitizers but lack miso's side effects. Stanford 
Research Institute developed SR-2508. 
"Our initial clinical trial was crucial be­
cause it would have indicated whether 
SR-2508's toxicities were similar to miso's. 
Administered intravenously and at dose 
levels three to four times greater than miso, 
we saw some side effects. But none was se­
vere enough to abandon SR-2508 as the best 
alternative to miso," says Wasserman. "No 
toxicities from such a drug would be best, 
but at least SR-2508 's side effects are pre­
dictable, reversible and don't overlap with 
any of the side effects from radiation ther­
apy or the cancer itsel f." 
According to reports at the Florida meet­
ing, only 25 percent of the 103 patients 
tested to date have complained of nervous­
system side effects related to SR-2508 ther­
apy. 'Those complaints," adds Jennings, 
"have been peripheral neuropathy, ex­
pressed as a numbness or tingling sensation 
in the extremities. Most patients describe 
the sensation as a feeling of 'pins and nee­
dles' or of having the limb' fall asleep. ' 





Todd Wasserman chnirs the group tho.i will 
test the radioJion-enhancing drug SR-2S08 
on cancer patients. 
effects, the nurses and physicians regularly 
ask patients if they are experiencing such 
feelings. The neuropathy always disappears 
when the treatments are halted. The tin­
gling sensations subside gradually. Within a 
two-month period, most patients can report 
some improvement." 
SUSPENDED ANIMATION 
The radiation-enhancing, or radiosen­
)" 	 sitizing, properties of drugs like miso and 

SR-2508 are based on the cellular charac­

teristics of solid tumors. On cross section, 

most tumors larger than a walnut reveal 

three regions that are distinguishable by 

their proximity to blood supply and, there­

fore, by the amount of oxygen they receive. 

, 	 The tumor's core, most removed from the 
capillaries, is so oxygen poor that the tissue 
is essentially dead and poses minimal 
threats to the patient. The outer ring of the 
tumor is closest to the blood supply. These 
peripheral cells siphon enough nutrients and 
oxygen from the blood to fuel the tumor's 
rapid, invasive expansion. The mid-region 
of the tumor, between the core and the outer 
ring, contains cells that are dormant , a state 
some liken to a "metabolic suspended ani­
mation. " They lack sufficient oxygen for 
rapid growth but can revitalize if the sur­
face of the tumor is stripped away, provid­
ing better contact with the blood supply. 
The oxygen-rich cells on the tumor 's sur­
face respond to chemotherapy and standard 
radiation therapy because these interven­
',- tions kill cells that are metabolically active 
and dividing. The oxygen-poor cells in the 
mid-region are protected from current 
therapies by their suspended animation. 
During a tolerable course of therapy, the 
treatments wipe out the peripheral cells. 
But after therapy is suspended, blood-borne 
oxygen revitalizes the remaining cells, and 
a relapse can occur as the tumor begins 
again to increase in size. 
~ The oxygen-poor, or hypoxic, region 
of tumors was documented 30 years ago: 
William Powers, M.D., and Leonard 
Tolmach, Ph.D., both of Washington u., 
were among the first to confirm the pres­
ence of the hypoxic region. When scientists 
realized that the hypoxic cells had a natural 
defense against radiation and chemotherapy, 
they set out to find ways of increasing the 
oxygen content of a tumor's hypoxic area. 
One of the earl iest methods for raising 
the oxygen content of these cells was what 
Wasserman calls the "sledgehammer ap­
proach." Patients were placed in a high­
pressure oxygen chamber in the hope that 
the high pressure would drive so much oxy­
gen into the blood that some of it would 
diffuse to the tumor 's central regions. 
Hyperbaric oxygen therapy was abandoned 
in the late 1960s for several reasons. The 
treatment was expensive, uncomfortable 
and difficult to administer safely. 
]n the mid-1970s, misonidazole came 
along. Laboratory tests with tumor cells, 
and later animal trials indicated that miso­
nidazole could, like oxygen, help increase 
the cancer cells ' DNA damage caused by 
radiation therapy. 
"The intriguing thing about miso is that 
it offered us the opportunity to have a sim­
ple, orally administered sensitizer that could 
be given right before radiation treatments," 
says Wasserman . 
Miso and its safer derivative, SR-2508, 
mimic the biochemical properties of oxy­
gen. "Radiation damages DNA in the cells 
it enters," explains Michael Welch, Ph.D., 
a Washington U. radiation chemist who has 
conducted considerable research on miso 
and miso derivatives and has collaborated 
with Wasserman. "]f an oxygen molecule 
or any other molecules with certain proper­
ties of oxygen are present in the tumor cell, 
that cell's DNA is more likely to sustain a 
double-strand rather than a single-strand 
break. The cell has mechanisms for repair­
ing single-strand damage, but a double 
break is usually lethal." 
FOOI1S GOLD 
"The body's cells treat SR-2508 like 
fool's gold," explains Wasserman. "Each 
cell passes the drug along. Eventually, SR­
2508 accumulates selectively in hypoxic 
cells, making it an ideal radiosensitizing 
agent. It has a specificity for just the group 
of cancer cells we are after." 
'This selective accumulation of miso and 
SR-2508 was something that was observed 
before it was predicted," adds Welch. 
"While we still don't understand why miso 
and its derivatives are deposited preferen­
tially in hypoxic tissue, we can nonetheless 
imagine many ways that such drugs could 
be used. They have great potential . Hypoxic 
tissue is either the cause or the result of a 
wide variety of diseases, including stroke 
and myocardial infarction as well as cancer. 
Because of this great potential, we have 
been working to prepare and manipulate 
miso analogs as radioactive drugs." 
Welch, along with a former Washington 
University researcher now working at the 
University of Washington, Kenneth A. 
Krohn, Ph.D., has demonstrated that a miso 
analog tagged with radioactive fluorine can 
be used as a positron tomography scanning 
agent. "In our animal studies, we've con­
firmed drug accumulation in tumors, and 
mapped damaged brain tissue," continues 
Welch . "Our guess is that it will be equally 
effective at outlining heart damage caused 
by myocardial infarct, and that it will be 
able to penetrate almost any other tissue 
we're interested in examining." 
In the immediate future, labeled SR-2508 
could well be used to help study how the 
radiosensitizer penetrates a tumor, resulting 
in information that could help optimize dose 
schedules and dose levels. Labeled SR-2508 
or other miso derivatives might also become 
useful diagnostic tools for the oncologist, 
revealing the presence and growth stages of 
secondary tumors, and perhaps even help 
screen high-risk patients for cancer. 
Clinicians will investigate several addi­
tional possibilities as clinical trials proceed, 
Wasserman predicts. While intravenous 
injection seems a reasonable way to ad­
minister SR-2508, several researchers 
wonder if the drug could be injected 
directly into the tumor. 
Although SR-2508 looks promising, 
several other sensitizing agents are on the 
horizon. Each of these will be tested on its 
own. "Also," says Wasserman, "we'l] ex­
amine whether these different agents can 
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Death in Peace or in Pieces 

1oltaire had reached the ripe old age of 81 when he wrote this, a remark­able age for his generation. He could 
not have written it two centuries later, in 
\986, because the otolaryngologist would 
have restored his hearing, the ophthalmol­
ogist would have removed hi s cataracts, and 
the orthopedist would have given him two 
total hip replacements. Furthermore, his 
heart disease would have been alleviated 
with a coronary artery bypass, and he 
would have received a kidney transplant 
to restore his renal function. However, it is 
obvious that Voltaire's cerebral functions 
were active, and that was hi s good fortune, 
because even with our technological 
achievements today, we could not have 
restored the "fail ing soul. " 
Today, the medical profession , the legal 
profession , sociologists and ethicists are in 
a quandary Technological advances in med­
icine and biomedical innovations can main­
tain respiration , circulation, metabolism 
and excretion into old age. But sooner or 
later, the brain deteriorates; what do we do 
then? Let us consider the following patient: 
An 87-year-old woman , mentally incom­
petent, fell as she was trying to get out of 
bed in the nursing home where she had 
been for four years. She was brought to hos­
pital, where it was found she had several 
fractures of the left thigh. She had a history 
of cardiac failure. She was not oriented to 
time, place or person, was obviously dehy­
drated and anemic, weighing 85 pounds, 
with two bedsores. She was not in severe 
pain. Because of a total hip replacement 
that had been performed ten years pre­
viously, and the nature of the present frac­
tures, the surgical opinion was that the only 
feasible operation was a total amputation 
of the left leg, a so-called hindquarter 
amputation. 
Should this patient with chronic brain 
syndrome have her leg amputated? If she 
survives, she will return - still with cogni­
tive brain function lost - to permanent 
disability in the nursing home. Or should 
she be made as comfortable as possible in 
her present condition? Obviously, the pa­
tient has a right to govern any intrusion of 
her body, but this patient's chronic brain 
syndrome made such decisions impossible. 
Failing that, her relatives should be con-
It is true that I am rather 
deaf, rather hi ind and 
rather crippled and that 
all this is capped by 
three or more atrocious 
inl'irmities; but nothing 
deprives me of hope. 
VoHaire, 177;'5 
suIted; but in this instance, there were none. 
Therefore, the ultimate decision rested with 
the attending physician, who may be uneasy 
with the concept that a certain patient may 
need less intervention, not more. 
Society and physicians face such dilem­
mas more frequently as the proportion of 
our aged population grows. Now 29 million 
or 12 percent of the population , it will dou­
ble by the turn of the century There are 
currently no official guidelines, and hope­
fully there never will be - every situation 
involving the terminally ill presents a 
unique set of circumstances. Yet the enor­
mous and increasing cost of Medicare sets 
the federal bureaucracy rumbling with the 
dilemma, how to contain costs? Inevitably, 
concepts about death will have to adapt to 
circumstances. In the last 20 years, medical 
technologies have mushroomed. They pre­
serve life at all costs - hence the growth 
of intensive care units. As Landau and 
Gustafson have stated, a "crusading mental­
ity" has come into being, and almost any 
means are justified to delay the enemy, 
death. But " the real enemies are disease, 
discomfort , disability, fear and anxiety" 
Individual groups attempt to solve these 
dilemmas. In 1984, under the auspices of 
the Society for the Right to Die, a group 
of physicians published "The Physician's 
Responsibility Toward Hopelessly III 
Patients." It indicates that any mechanical 
or surgical intervention should be discour­
aged if it does not make the patient comfort­
able. Moreover, they believe that "severely 
and irreversibly demented patients need 
only care to make them comfortable. Sense­
less perpetuation of the status quo is deci­
sion by default." 
In Canada, a Law and Reform Commis­
sion, composed of leading lawyers, has 
established a "Protection of Life Project." 
After pointing out that committing euthana­
sia and aiding suicide are criminal acts, they 
discussed factors culminating in the deci­
sion to end medical treatment, thus leading 
to death. They indicate that the value of life 
should be considered, not only from a 
"quantitative" perspective but also from 
a "qualitative" viewpoint. Incompetent pa­
tients should have the right to die in peace 
and dignity, assisted by palliative care. 
Practically speak ing, what can be offered 
to assist the patient who wants to end life 
in peace and dignity? 
In 16 states today, including Missouri , 
a " living will" law permits a person to pre­
pare a written statement of the care pre­
ferred in the event of a terminal illness. 
Such a statement is useful to the attending 
physicians and spares relatives from making 
heart-rending decisions. 
Recently, an independent state-wide body, 
Oregon Health Decision, undertook a proj­
ect to address and resolve problems relating 
to: I) the rationing of health care, exacer­
bated by the push to contain costs; 2) tech­
nological advances that outrace the ability 
to pay for, or even understand , them; and 
3) the protection of the "autonomy and dig­
nity of dying patients from the tyranny of 
treating for treatment's sake" (lAMA 254: 
3213-6, December 1985). Among other 
things, this project has heightened the pub­
lic 's awareness of the di lemmas and their 
solutions. 
We all face problems created by care of 
the failing older patient. The primary aim 
of medical professionals has become preser­
vation of life at any cost. Perhaps, death in 
., 
a peaceful and humane fashion may provide 
more "salvation for the soul. " 
C Ron Stephen, MD., CM 
Clinical professor ofanesthesiology 
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n his spare time, second­
year student John Constan­
tino is making a baby ... 
a MacBaby, to be precise. 
MacBaby shows, in step-by­
step fashion, the developmental 
events that transform the hu­
man egg into a fetus. Constan­
tino's extracurricular tinkering 
with the Macintosh computer 
is supported by the Medical 
Alumni Association via its 
Teacher of the Year award. 
Four-time winner Roy R. 
Peterson, Ph.D., professor of 
anatomy, used the funds from 
this award to purchase the 
computer and software and to 
pay Constantino to develop the 
animated drawings. 
MacBaby portrays, in three 
dimensions, an overview of 
human development. The com· 
puter "movie" grew out of 
Constantino's frustration that 
surfaced several times over the 
course of his pre-medical 
career - his inability to 
mentally picture the three­
dimensional events that occur 
in biological phenomena. 
"Embryology always inter­
ested me," says Constantino. 
"When I started my first-year 
studies, I took anatomy, which 
included an embryology sec­
tion in the course and an elec­
tive. In one of those classes, 
they flashed up a slide - a pic­
ture of a bilamjnar germ disk. 
It looked to me like a swim­
mjng pool. When I saw it, sud­
denly everything I'd been 
struggling with just clicked. 
"A few months later, I was 
studying for a final in histology. 
We were studying the placenta , 
but I never had really under­
stood the anatomjcal relation­
ship between the placenta and 
the embryo. I thought, 'There's 
got to be a better way to under­
stand how they relate.' Then, 




Roy R. Peterson (left) and John Constantino have created a computer "Inovie" that charts the 
course ofdevelopment from egg to embryo. 
pool picture. And I got so ex­
cited thinking about how it all 
fit together that I blew off 
studying for my histology test, 
and jllSt spent the rest of the 
night making sketches." 
Soon after, Constantino 
showed his sketches to Peter­
son and Jane PhillipS-Conroy, 
Ph.D., his anatomy and em­
bryology instructors, respec­
tively; he wanted to write a 
book: "I was prepared for them 
to laugh me right out of their 
offices, but they didn't. They 
were very encouraging." 
It was Peterson, though, 
who came up with the idea of 
creating a computer movie 
rather than a book. Constan­
tino, no hacker, wasn't enthusi­
astic; he'd had no experience 
with computers. But a few 
weeks of learning to manipu­
late the Macintosh mouse 
through MacPaint (an easy­
to-use software package), then 
mastering VideoWorks (the ani­
mation program), won him 
over. Since he had already 
thoroughly researched the em­
bryological events he wanted 
to portray, the only time­
consuming part was creating 
the individual drawings neces­
sary for animation . 
"The program makes it easy 
to move images from place to 
place on the screen," explains 
Constantino. "But in order to 
make the shape of an image 
change - which most of em­
bryology really is - you have 
to draw separate pictures 
for each change, just like a 
cartoon. In ordinary two­
dimensional drawings, it's im­
possible to see the twisting and 
folding that are the important 
embryological events. And 
that's the important thing to 
understand - how this ball of 
cells can twist into layer upon 
layer, and invaginate upon it­
self. Once you understand that, 
the rest you can get out of 
a textbook. " 
MacBaby portrays the for­
mation of the basic body plan, 
including the three germ layers 
and the "tube within a tube" 
design of the body. 
"I think the program has 
gone about as far as it can be­
cause the more complicated, 
further developments require 
more attention to detail," says 
Constantino. "But I would like 
to get in two more systems ­
the uro-genital system, and the 
formation of the circulatory 
system - how the heart devel­
ops, and the switch from pla­
cental to mature circulation." 
Peterson's role included 
meticulous checking of the sci­
entific events Constantino drew 
and the narrative text describ­
ing these events. "I made lots 
of mistakes on the science," 
says Constantino, "but Dr. 
27 
Peterson never made one 
change without telling me first 
and asking me what I thought. 
He tells me, 'This is your story 
- you tell it your way, I don't 
want to interfere, because I like 
the way you say things.' " 
Constantino explains that 
this is Peterson's natural style, 
one that he displays in his role 
as anatomy instructor for all 
first-year students: "He never 
forces his way on anybody ­
he wants people to learn on 
their own . He knew that be­
cause I had just learned all this 
myself, I could teach others to 
go through the learning pro­
cess. He knows that each stu­
dent must go through the learn­
ing process on his own, in his 
own way. Dr. Peterson's just the 
ultimate teacher." 
Peterson traveled to San 
Francisco in January, at the 
invitation of Macintosh, to 
participate in a three-day dem­
onstration of computer applica­
tions. His was one of 24 univer­
sity exhibits showing either 
software or teaching programs 
that had been developed for the 
Macintosh by academic institu­
tions. Repeatedly, says Peter­
son, the $15-a-head visitors 
expressed admiration for 
Constantino's work. 
Once back from the confer­
ence, Peterson phoned the 
software company, who had al­
ready heard of Constantino's 
work: ' 'The person who an­
swered the phone said, 'Oh, 
yes, MacBaby. Your disks 
caused us to rewrite our pro­
gram,' " remembers Peterson. 
He explains that the original 
version of VideoWorks called 
for text to be entered as a 
graphic, which takes more 
memory. The revised version 
of the software will allow Mac-
Baby to be compressed to one 
or one-and-a-half disks from 
its present three-disk version. 
Eventually, says Peterson, 
they may market Mac Baby 
after Constantino finishes the 
uro-genital and circulatory sys­
tems. ''The student evaluations 
of John's work have been very 
positive," reports Peterson, 
who asked first-year students 
to give them feedback on the 
movie. "We plan to use it as 
a supplement to the textbook-
only phase of the course. And 
people who stopped by our 
exhibit at the conference-
physicians, lawyers, and non­
scientists - all said the same 
thing: ' I wish I'd had that when 
I took embryology.' " 
''The things I like are 
simple," muses Constantino, 
whose goal is to go into family 
practice or general surgery. 
"I want to find a niche where 
somebody needs me; I don't 
want to compete with anybody, 
even though I'm a very com­
petitive person, because that 
misses the point." 
His goal in creating Mac-
Baby, he says, "derived from 
my frustration as a student, 
sitting in lecture and wonder­
ing, 'Where did that come 
from?' I thought, if nothing 
else, I wanted to leave nothing 
out in describing how to get 
from an egg to an embryo. Dr. 
Peterson knew I felt that way 
and that it would take time to 
use such an approach. Yet, he 
still said, 'Do it one step at 
a time - don't compromise 
your view because of time, 
do it right.' And t11at's what 
we did." 
Edward W. Cannady, 
M.D. '31, and Robert W. 
Elliott, M.D. '36, are chairing 
the reunions of their respective 
classes at the 1986 Medical 
Alumni Reunion. 
Kenneth A. Koerner, 
M.D. '41, is hosting his class 
at this year's reunion. 
Virgil Loeb, M.D. '44, 
clinical professor of medicine 
at Washington University 
School of Medicine, has been 
elected vice-president and 
president-elect of the American 
Cancer Society. Loeb is a med­
ical oncologist at Barnes 
Hospital. 
Willard B. Walker, M.D. 
'46, invites his former c1ass­
mates to the festivities at this 
year's reunion . 
James W. Owen, M.D. 
'46, and Everett R. Lerwick, 
M.D. '48, are medical director 
and owner, respectively, of the 
Lerwick Clinic, newly opened 
in downtown St. Louis. The $7 
million facility will eventually 
have 30 full-time physicians 
who supervise diagnosis, out­
patient surgery, and preventive 
medicine. 
J. Neal Middelkamp, 
M.D. '48, professor of pediat­
rics at Washington University 
School of Medicine, has been 
elected secretary-treasurer of 
the American Board of Pediat­
rics. He is a member of the 
board's residency review 
corruni ttee. 
Elizabeth Happel, M.D. 
'49, has been honored by the 
New Milford Hospital board 
for her role in the Connecticut 
hospital's building campaign 
and her 29-year practice there. 
Happel, who has delivered 
more than 5,500 babies, will 
discontinue practicing obstet-
J 
rics but provide gynecology 
services. She plans to train in 
microsurgery so that she can 
specialize in treating infertility, 
which includes performing 
reverse sterilizations. 
Happel has contributed to 
many professional corrunittees, 
including the medical educa­
tion corrunittee of the Maternal 
and Child Care Division, 
which she headed. She also 
served as medical staff repre­
sentative to the hospital's 
board. 
Happel completed residen­
cies at Bellevue Hospital and 
French Hospital in New York. 
Before moving to Connecticut, 
she taught at several New York 
hospitals. Recently recertified 
by t11e American Board of 
Obstetrics, Happel was recog­
nized by the AMA for her con­
tinuing medical education. 
Walter A. German, M.D. 
'51, contributed an editorial on 
tort reform as a legislative ." 
priority to the Missouri State 
Medical Society Magazine, 
Missouri Medicine. German is 
president of that organization. 
Marvin E. Levin, M.D. 
'51, welcomes his former c1ass­
mates to the 1985 Alumni 
Reunion. In addition, he has 
led the Medical Eliot Society to 
a new milestone: In only two 
years, he and his corrunittee 
have secured the endowment 
for the second Alumni En­
dowed Professorship by enlist­
ing 145 new members. What's 
more, the corrunittee has led 
the medical school halfway 
toward the endowment needed 
to fund the third AEP "I think 
we can do it by July," says 
Levin. 
The goal is to eventually 
endow one AEP in each of the 
School of Medicine's 18 clinical 
and preclinical departments. 
"When you're in a great place 
like Washington University 
Medical Center," remarks 
levin, "it generates good feel­
ings; helping the institution is 
only a reflex . It stimulates you 
to want to do something for 
those yet to come, to leave a 
heritage - excellent teachers. 
lowe this place something." 
Robert E. Hermann, 
M.D. ' 54, heads the board 
of the American College of 
Surgeons. Hermann, chairman 
of the Department of General 
Surgery at Cleveland Clinic 
Foundation, was elected last 
fall to represent the 220 gover­
nors on the association's Board 
of Regents. He joined CCF in 
1962 after completing intern­
ship and residency in surgery 
at University Hospitals of 
Cleveland. 
Richard W. Hudgens, 
M.D. '56, is hosting his class 
reunion this spring. 
Samuel S. Kurohara, 
M.D. '57, has been named a 
fellow of the American College 
of Radiology A native of 
Hawaii, Kurohara is on the 
medical staffs at several hospi­
tals, including the Beverly Hos­
pital in Montebello, CA, and 
the LAC/USC Medical Center 
in Los Angeles. 
Morris Reichlin, M.D. 
'59, is professor of medicine 
and chief of immunology at the 
University of Oklahoma. He 
was a participant in a rheuma­
tology symposium held in 
Binningham, AL, last fall. 
o(~ 
Floyd E. Bloom, M.D. '60, 
has been elected to the board 
of the American Association 
for the Advancement of Sci­
ence. His four-year term begins 
May 31, 1986. Bloom, director 
of the division of preclinical 
neuroscience and endocrinol­
ogy at the Scripps Clinic and 
Research Foundation in La 
Jolla, CA, was the subject of 
the "Silhouette" in the winter 
1985 issue of Ou/wok. 
Nicholas T. Kouchoukos, 
M.D. '61, and Harold S. 
Zarkowsky, M.D. '61, are 
co-hosts of their class reunion. 
Richard Marchick, M.D. 
'61, is serving a three-year 
term as vice-chairman of the 
California Bay Area Section 
of The American College of 
Obstetricians and Gynecolo­
gists. In private practice in 
Berkeley, Marchick is on staff 
at Alta Bates Hospital, where 
he chaired obstetrics/gynecol­
ogy and served on the medical 
executive board, and at Herrick 
Hospital. He is associate clini­
cal professor of obstetrics and 
gynecology at UCSF School of 
Medicine. Formerly, he was 
president of the East Bay 
Gynecological Society and is a 
member of several professional 
organizations. 
Ronald E. Rosenthal, 
M.D. '61, is chief of the 
trauma service in the Depart­
ment of Orthopaedic Surgery 
at the Long Island Jewish Med­
ical Center in New Hyde Park, 
New York. Rosenthal also 
heads orthopedics at the 
Queens Hospital Center and is 
associate professor of clinical 
orthopedics at the State Univer­
sity of New York Health Sci­
ences Center at Stony Brook. 
Rosenthal, who formerly 
lived in Nashville, writes that 
he is looking forward to his 
25th class reunion in May 
John Stone, M.D. '62, has 
prepared a third book of 
poems, Renaming the Streets, 
published by Louisiana State 
University Press (Baton Rouge, 
LA 70893). The book is de­
scribed as " ... a work that 
speaks to the future but re­
mains mindful of the endless 
intersection of the past and the 
present. Stone writes about the 
human experience in all its sea­
sons: if there is suffering, pain, 
loneliness, there is also love, 
mercy, humor, and, always 
a sense of wonder ... " 
Stone, associate dean at 
Emory University School of 
Medicine, was profiled in the 
summer 1984 issue of Ou/Wok. 
Roger L. MelI, M.D. '65, 
heads the council of the South­
ern Medical Associations. An 
orthopedic surgeon practicing 
in St. Louis County, MO, Mell 
trained in general surgery at 
Barnes and St. Luke's hospitals 
in St. Louis and in orthopedic 
surgery at Barnes and allied 
hospitals. Before entering med­
icine, he was a pilot in the U.S. 
Air Force. 
Ronald K. Grady, M.D. 
'66, and Jay L. Liss, M.D. 
'66, are co-chairing their class 
reunion this spring. 
Johnny Bliznak, M.D. '67, 
is a fellow of the American 
College of Radiology. A native 
of Texas, Bliznak is on staff at 
the Hendrick Medical Center 
and the Humana Hospital­
Abilene (TX). 
Lynn M. Taussig, M.D. 
'68, is professor and head of 
pediatrics at the University of 
Arizona College of Medicine. 
He had been acting head of that 
department since last July and 
associate head since 1979. 
Taussig, a specialist in pedi­
atric pulmonary disease, is the 
principal investigator of a five­
year, $1 million grant to study 
children's risk factors for acute 
and chronic lung diseases. His 
special interest is cystic 
fibrosis. 
He serves on the pulmonary 
diseases advisory committee of 
the National Heart, Lung and 
Blood Institute. He is also on 
Lylm M. Taussig 
Robert E. Hernuum 
the editorial boards of two the American College of Pre- Peabody College. She com- co-authored a paper on compli­
professional publications. ventive Medicine. He has been pleted a residency in psychiatry cations of spinal instrumenta- ]\0--' 

Formerly the vice-chairman of a consultant for several over- at Washington University fol- tion. His work was featured in 

the medical advisory council of seas health projects and lowing graduation from medi- the winter 1985 issue of 

the National Cystic Fibrosis organizatjons. cal school there. She earned an OU/look. .jl _ 

Foundation , Taussig assisted in Dixie J. Aronberg, M.D. MPH in Mental Health Admin- Pamela Freeman, M.D. 

the development of a pediatric '71, is heading her class istration from Jotms Hopkins '77, FHS, is a rheumatologist 

pulmonary examination for the reunion this spring. School of Public Health and in practice in Orlando, FL. 

American Board of Pediatrics. Lary A. Robinson, M.D. Hygiene. Board-certified in Charles O. Hershey, M.D. 

A 1964 cum laude graduate '72, is a fellow of the Ameri- psychiatry, she is a diplomate '77, is a fellow of the American 
of Harvard, Taussig earned his can College of Cardiology. of the American Board of Psy- College of Physicians. An in-
medical degree at Washington Currently, he is staff cardio- chiatry and Neurology. Newton ternist , Hershey is on staff J. 
University. Then , he went for thoracic surgeon at the Uni- also has certification in admjn- at Cleveland Metropolitan 
further training to the Univer- versity of Nebraska Medical istrative psychiatry from the General Hospital. 
sity of Colorado, the National Center, Omaha . American Psychiatric Cecil J. Holliman, M.D. 
Institutes of Health, and The Wishwa N. Kapoor, M.D. Association. '79, has been accepted as a 
Montreal Children's Hospital. '75, has been elected a fellow Kenneth S. Rotskoff, member of the Berks County 
Taussig returned to Tucson in of the American College of D.D.S., M;D. '75, moderated Medical Society (PA). He prac­
1974 after completing a clinical Physicians. Kapoor, an intern- the Symposium on Nutrition tices emergency medicine at 
fellowship from the National ist, is on staff at Presbyterian- for the Oral and Maxillofacial Community General Hospital. 
Cystic Fibrosis Research University Hospital , Pittsburgh. Surgeon at a meeting in Wash- Carol Mitchell Simmons, 
Foundation. Patricia Newton, M.D. ington, nc. , last fall. He also M.D. '79, has begun a resi­
'75, psychiatrist-in-chief of presented abstracts of his work dency in family medicine at the 
Provident Hospital, Baltimore, on surgical orthodontic Mayo Graduate School of
"7()S was honored by Essence patients. Medicine, Rochester, MN. 
Magazine for her contributions Robert L. Lamberg, M.D. 
Robert G. Harmon, M.D. in health and medicine. In '76, has been selected to serve 
'70, is the director of the 1983, Newton was cited by on the Executive Council of the 
.. 
newly-created Missouri De- Baltimore Magazine as one of Medical Center Alumni Asso­
partment of Health. Formerly, the city's 100 most influential ciation . A St. Louis ophthal­ r 
he served as director of public women. mologist, Lamberg is clinical David A. McLain, FHS 
health and was health officer In 1985, she chaired the First instructor of ophthalmology at '75-9 and former faculty ' 79­
for Maricopa County (AZ). Baltimore International Con- the School of Medicine. He 81, is chief of rheumatology at 
As director of the MDOH, gress of Transcultural Psy- also chairs the Medical Cen- Brookwood Medical Center in 
Harmon oversees seven district chiatry, co-sponsored by the tury ClUb, an organization of Birmingham, AL. He was 
offices. Its programs are in NIMH. Newton is assistant medical alumni who are uni- course director for the third 
environmental health and professor of psychiatry at Johns versity donors. Lamberg also annual Brookwood Rheumatol­
epidemiology, health resources, Hopkins and president of serves as reunion chairman for ogy Symposium. Speakers in-
personal health services, and Newton-Thoth , Inc., an inter- his class. c1uded C. Conrad Johnston , 
local health and institutional national behavioral science Keith H. Bridwell, M.D. FHS '56-7, director of the divi­
services. management consultant corpo- '77, assistant professor of sion of endocrinology and 
After graduating from ration. A member of the Amer- orthopedic surgery at Washing- metabolism, Indiana University 
Washington University School ican Psychiatric Association ton University School of Medi- Medical Center. Thomas ~... 
of Medicine, Harmon earned and the Black Psychiatrists of cine, chose "Surgical Treat- Traylor, FHS '75-8, was on the 
an M.P.H. from Jotms Hopkins America, she is a frequent ment of Spine Burst Fractures" program committee; he is a 
University in 1977. Board- media spokesperson on health- as the subject of an audiotape Birmingham rheumatologist. .. 
certified in preventive medi- related matters. he made for a national organi- Harry Burack, FHS in 
cine, he completed a residency After completing her under- zation for continuing medical gastroenterology, recently 
in internal medicine. He is a graduate work at University of education. He also has com- opened a private practice in 
fellow and board member of Arkansas (Pine Bluff), she pleted a book chapter on the St. Peters, Mo. 




Keith LaFerriere, FHS, 
has been named clinical assis­
tant professor, Department 
of Surgery, divi sion of oto­
laryngology, at University of 
Missouri School of Medicine 
(Columbia). A member of 
Head and Neck SurgicaJ Asso­
ciates of Springfield Ltd. , 
LaFerriere previously served 
as research associate at Kresge 
Hearing Research Institute and 
instructor of otolaryngology at 
Washington University School 
of Medicine. A fellow of the 
American College of Surgeons 
and the American Academy of 
Facial Plastic and Reconstruc­
tive Surgery, he is president 
of the Missouri Society of 
Otolaryngology - Head and 
Neck Surgery. 
Keith LaFerriere 
Ramon Iglesias, FHS, 
practices obstetrics and 
gynecology in Coral Gables, 
FL. An article about him in 
the Miami Herald describes his 
advocacy of sports, especially 
for women. 
Harold H. Sandstead, 
FHS, is professor and chair­
man of the Department of 
Preventive Medicine and Com­
munity Health at the University 
of Texas Medical Branch, 
Galveston . A noted researcher 
in human nutrition, Sandstead 
previously served as professor 
of nutrition at Tufts University 
and senior scientist and direc­
tor of the USDA agricultural 
research service. He received 
the M.D. from Vanderbilt in 
1959, then completed residency 
in internal medicine at Barnes 
Hospital and at Vanderbilt Uni­
versity Hospital. His world­
wide scientific reputation is in 
the field of trace mineraJ 
metabolism, particularly zinc. 
II 
Lawrence E. Acker is ad­
ministrator of the MEDICAL 
Rehabilitation Center of St. 
Louis, a comprehensive out­
patient rehabilitation facility. 
A 1979 graduate of HAp, he 
formerly was associate admin­
istrator at St. Louis County 
Hospital. 
Jeffrey M. Fried has been 
named vice president of opera­
tions at Lancaster General Ser­
vices Corp., PA. Formerly, he 
was assistant vice president of 
Sinai Hospital, Baltimore. 
Dana S. Hensley is assis­
tant vice president at Baptist 
Medical Center, Montclar, AL. 
Hensley is a Ph.D. candidate 
in religion at Vanderbilt 
University. 
Mark S. Wiener joined 
Research Medical Center 
(Kansas City, MO) as vice 
president of clinical services. 
Previously, he was assistant 
hospital director at University 
of Nebraska Hospital and 
Clinic in Omaha . 
Mark S. Wiener 
Ned Wilford was inter­
viewed in the November 1985 
issue of Referee. Wilford, who 
earned the master's degree in 
HAP in 1966 and is president 
of Holmes Regional Medical 
Center in Florida , is also a 
Southeastern Conference foot­
ball official. 
His interest in sports dates 
back to his high school days: 
He played on a team ranked 
number one in his home state, 
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nsurance charts have no category for 
physicians who fly jet airplanes. But 
Thomas E Frist, Jr. , M.D. '65, is an 
experienced jet pilot who has flown on busi­
ness all around the country. And conven­
tional wisdom has it that medicine and busi­
ness don't mix. But Frist , chairman and 
C.E.o. of the Hospital Corporation of 
America (HCA), has mixed medicine and 
business skillfully enough to earn a piece 
of corporate history. 
"I have had a burning, compulsive, 
almost obsessive desire to prove that it's not 
inconsistent for a physician to be a capable 
manager," says Frist. The Nashville-based 
company, which he helped found in 1968 
- three years after graduating from Wash­
ington University School of Medicine ­
has also defied skeptics: It has rapidly 
grown into the largest hospital management 
chain in the U.S. In 45 states and seven 
foreign countries, HCA currently owns or 
operates 438 health care facilities. Reaching 
into related fields, it has also acquired an 
ambulance subsidiary, a nursing home com­
pany and a medical equipment leasing firm. 
In 1986, HCA will garner $5 billion in reve­
nues and employ more than 80,000 people. 
Frist, a soft-spoken man with an easy 
southern drawl, continues to act aggres­
sively and seize the unexpected . Last year, 
he surprised Wall Street by forging a giant 
alliance between HCA and American Hos­
pital Supply Corp., the nation's largest dis­
tributor of hospital supplies. The merger 
fell apart , but HCA emerged with $150 
million, which Frist will turn to fresh 
advantage. 
"The most recent strategy of HCA," 
discloses Frist, "is to develop the national 
provider network to serve the insurance in­
dustry and corporate America. We will do 
that through owned, managed and affiliated 
hospitals, both in communities where we 
are now and by filling gaps over the next 
two years in the few areas where we do not 
have a network." 
This major new thrust for HCA, Frist 
hints, will mean several joint ventures 
within the insurance industry. It will also 
require state-of-the-art computer and com­
munication systems to link hospital , physi­
cian's office, workplace and insurance com­
pany. Aided by increasingly close ties with 
32 
"Goingfrom a cost-plus payment system to a competitive, market-driven system has 
chmlged the course ofmedicine," says Thomas Frist, founder ofHospital Corporation of 
America (HCA). (photo courtesy ofHCA) 
local physicians, "we will build the system 
of the future, " he says. 
Growing up in a family full of physi­
cians, Frist learned early about health care. 
His father, Thomas E Frist, Sr. , was a lead­
ing Nashville cardiologist and an associate 
professor of medicine at Vanderbilt 's School 
of Medicine. One brother became a cardiac 
surgeon; a second joined the heart trans­
plant program at Stanford. Cousin John 
Frist , M.D. '66, went on to practice plastic 
surgery in Nashville. 
From childhood , Frist had his sights 
set on surgery. After undergraduate training 
at Vanderbilt , he decided to broaden his 
experience and was drawn to Washington 
University by its strong reputation. Imme­
diately, he was impressed by the spirit of 
cooperation between professors, house staff 
and medical students. 
"The professors not only took pride in 
research, they also enjoyed teaching. This 
combination created an exciting climate for 
medical students. You saw that with Dr. 
Carl Moore of the Department of Medicine, 
Dr. Carl Moyer of surgery, and Dr. [Lauren] 
Ackerman in pathology. They were there, 
participating in rounds ; they made medical 
students feel as if they were part of a team . 
In business, we call that a ' corporate cul­
ture.' Washington University has a unique 
'culture' for a medical center and should be 
the envy of all others," he says. 
Returning to Vanderbilt, Frist completed 
his surgical internship and was beginning 
his residency when he was drafted to serve 
as an Air Force flight surgeon during the 
Vietnam War. That stint gave him time to 
ponder a lesson he'd learned from a college 
fraternity brother, son of a Holiday Inn 
founder : "Holiday Inns of America created 
the motel business," muses Frist. "Until that 
time, travellers had two choices - boarding 
houses or uptown hotels. I realized that 
there were 7,000 independently-operated 
hospitals being run as a cottage industry. 
The same opportunity existed there as in 
the hotel industry." 
, 
Discharged from the service and three 
months away from returning to his resi­
dency, Frist went to Vanderbilt's head of 
surgery with two decisions: He was not re­

turning to complete his training, and he was 

going to start a for-profit hospital company. 

"You can imagine what the reaction was," 

Frist says wryly. "I was concerned too. 

I knew there was tremendous potential, but 

there was also a great deal of risk." 

From the start, Frist had high-powered 
help from co-founders Jack C. Massey, 
... 	 whose business acumen derived from his 
roots in Kentucky Fried Chicken; and from 
the senior Frist, whose own Parkview Hos­
pital (acquired during the 1950s) formed 
the nucleus of the fledgling HCA. After 
only 18 months, the new firm had II hospi­
tals; soon, HCA developed its lasting pat­
i tern of doubling in size every three years. 
At first , Frist concentrated on acquisition 
and development. "That was where I was 
,. able to use my background in medicine, my 
love of business, and my hobby of aviation," 
he says. "I put all three together and went 
personally to visit communities, meet 
doctors and see hospitals." 
-4 Frist targeted the southeast US., then 
experiencing tremendous growth. Capital­
• 	 starved communities were scrambling to 
finance new schools or public utilities; they 
"I lacked money to improve outdated hospi­
tals. "We were not necessarily the first or 
even the second choice," Frist says. "If the 
local government or religious order could 
not fulfill the need, we were often - at 
least in the early years - the answer of last 
.,)
,.. 	 resort. Gradually, we built a track record 
which allowed us to take on larger and more 
• 
prestigious projects." 
1"" After five years in business, HCA no 
longer limited itself to eligible proprietary 
• 	 hospitals; communities began selling the 
firm their not-for-profit hospitals. A few 
~ 
4 years later, hospitals were seeking out HCA 
to manage their tax-exempt facilities. Today, 
approximately half HCA's hospitals are tax­
~. 	
able; the rest are tax-exempt. 
1 
"But in 17 years, those artificial designa­
tions have blurred, just as they have in the 
financial world," reflects Frist. "It is diffi­
cult today to tell a bank from a savings and 
loan from an investment banking house. 
Likewise, you have the traditional not-for­
profit hospital with for-profit subsidiaries 
and for-profit hospitals with not-for-profit 
subsidiaries. " 
The scope of HCA's business has also 
changed. No longer simply a hospital chain, 
it has become a fully integrated health care 
system that provides wide-ranging care: 
in-patient, out-patient, home health, long­
term and psychiatric, 
And like HCA, the entire US. health 
care system is in flux, prodded by 1983 
changes in Medicare reimbursement policy. 
"If that hadn't occurred, the alternatives 
were not bright," Frist says. "We were 
marching down the road very rapidly 
toward socialized medicine - and, ulti­
mately, a national health system - as a re­
sult of uncontrolled, double-digit inflation. 
This bold, dramatic change - going from 
a cost-plus payment system to a competi­
tive, market-driven system - has changed 
the course of medicine. The system has be­
come, in a relatively short time, far more 
cost-effective than I could ever have . 
dreamed." 
That process is taking a toll, he adds. 
Over the next decade, probably 400 to 500 
hospitals will close. Others, including uni­
versity medical centers, will join hospital 
groups to create new kinds of affiliations 
- joint ventures, management contracts, 
equity investment, and outreach programs 
that stretch beyond their geographical 
boundaries. 
HCA will playa central role in these new 
developments. Already, Frist says, the firm 
has made an important difference to the 
quality of American health care. In commu­
nities where HCA has built or acquired a 
hospital, he contends, the patients are now 
receiving better health care; in communities 
where an HCA hospital exists alongside 
others, its presence has given its com­
petitors the incentive to improve. 
Frist is starting to look ahead to the end 
of his leadership of HCA. Named president 
in 1978, he learned the skills of manage­
ment from Donald S. MacNaughton, former 
C.E.o. of Prudential Insurance who joined 
HCA as chairman in 1979. Frist became 
C.E.O. in 1982 and chairman last Sep­
tember: "My feeling is that a person can be 
effective as C.E.O. of a major company for 
a maximum of eight to ten years," he says. 
Within five to six years, he may consider 
moving on to other opportunities in health 
yare, leaving his company" . .. in an emi­
nent position, where it will have a bright 
future. " 
To harness the energy for the corning 
critical years, Frist relies on exercise. A de­
voted jogger who frequently runs during 
airport stopovers, he has completed 16 
marathons. He balances his other respon­
sibilities, which include national-level work 
for the United Way, with a strong commit­
ment to his family: wife and former child­
hood sweetheart Patricia Gail Champion, 
and three children. 
Although he has never practiced medi­
cine, Frist is grateful for his medical train­
ing. It was useful through HCA's early 
years, facilitating his communication with 
physicians. But during HCA's growth spurt, 
it occasionally hindered him; he had to 
prove his mettle as a Fortune 500 company 
executive. With the nation's sharpened 
focus on health care delivery systems, how­
ever, his training has re-emerged as an asset 
in building his - and HCA's - credibility. 
He says that he will always bear fond 
memories of Washington University. For 
one thing, HCA continues to draw on the 
Health Administration Program (HAP) at 
the School of Medicine for its managerial 
staff. "And I know that having attended the 
medical school, with its great tradition as a 
center of excellence, has provided me with 
intangible benefits greater than I can mea­
sure. I'm very appreciative of that." 
He is also thankful for his chance to 
shape a vital American industry. "I've en­
joyed playing a role in the changing of 
America's health care delivery system, It 
has always been thought of as synonymous 
with quality. Now we're demonstrating that 
we can be effective managers as well." 
Candace 0'Connor is a free-lance writer and 
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"Speaking Jor the Hearf' is t~ title ofthe 1985 annual report 
poster issued by the Washington University Medical Cenler. This 
iIlllstraliml, one oJnwre than 10 on the poster, depicts surgical 
treoJmentJor coronary artery disease. In t~ prtJretlure, diseased 
coTOlUUY arteries are bypassed with grqfts as shown. The pa­
tient's own internal mammary arteries and veins can c1uuureIan 
utUJbstructed supply ofbloodto ischemic heart muscle, relieving 
symptoms like angiTlll. 
A limiled supply oJ"Speaking Jor the Hearf' posters is aMil­
able. 10 oblLlin a copy, pkose call 314-362-8258. 
